Optimizing Protein Refolding: A Complete DnaK/DnaJ/GrpE Chaperone System Protocol for Biomedical Research

Abstract

This article provides researchers, scientists, and drug development professionals with a comprehensive guide to the DnaK/DnaJ/GrpE (Hsp70/Hsp40/NEF) chaperone system for protein refolding. We cover the foundational biology of this essential bacterial chaperone trio, present a detailed, optimized step-by-step refolding protocol applicable to aggregated or misfolded proteins, and address common troubleshooting scenarios. The guide also includes methods for validating refolding success and compares the KJE system to other refolding strategies. Our goal is to deliver a practical, current resource to enhance yield and reproducibility in protein research and therapeutic development.

Understanding the KJE Chaperone Machine: Core Biology and Refolding Principles

This document serves as foundational Application Notes and Protocols for research within the broader thesis "Optimization and Mechanistic Analysis of DnaK/DnaJ/GrpE (KJE)-Mediated Protein Refolding." The Escherichia coli Hsp70 system, comprising the chaperone DnaK, the co-chaperone DnaJ, and the nucleotide exchange factor GrpE, is a quintessential model for understanding ATP-dependent protein folding, disaggregation, and stability. Its functional interplay is critical for cellular proteostasis and a template for studying analogous systems in higher organisms. Mastery of its in vitro reconstitution is paramount for thesis research aimed at developing refined refolding protocols for biotechnological and therapeutic protein production.

The Functional Trio: Core Mechanisms & Quantitative Parameters

The KJE system operates through a finely tuned ATPase cycle. DnaJ binds to exposed hydrophobic segments of substrate proteins (clients) and recruits ATP-bound DnaK, stimulating its ATP hydrolysis. This locks the client in DnaK's binding cleft. GrpE then catalyzes ADP release, allowing ATP rebinding and client discharge. The cycle repeats until the client is properly folded.

Table 1: Key Quantitative Parameters of the Core E. coli Hsp70 System Components

Component	Molecular Weight (kDa)	Key Functional Rate Constants	Typical In Vitro Concentration in Refolding Assays
DnaK (Hsp70)	~70	ATPase rate: ~0.02 min⁻¹ (alone); ~1-2 min⁻¹ (+DnaJ). Kd for peptide: ~0.1-1 µM (ADP-state).	0.5 – 5.0 µM
DnaJ (Hsp40)	~41	Stimulates DnaK ATPase >50-fold. Binds clients with µM-nM affinity.	0.1 – 1.0 µM (Often at 1:5 to 1:10 ratio to DnaK)
GrpE (NEF)	~22 (Dimer)	Reduces DnaK's affinity for ADP by ~100-fold; exchange rate >1000 s⁻¹.	0.2 – 2.0 µM (Often at 1:2 to 1:5 ratio to DnaK)
ATP	-	Hydrolyzed to ADP; required for cycling. Mg²⁺ is essential cofactor.	1 – 5 mM

Table 2: Example Refolding Yields for Model Substrates with KJE System

Denatured Substrate	Initial Concentration	Optimal KJE Ratio (K:J:E)	Refolding Buffer	Incubation Temp & Time	Approximate Refolding Yield	Key Citation Insight
Luciferase (Firefly)	50 nM	2 µM:0.4 µM:1 µM	25 mM HEPES-KOH, pH 7.6, 50 mM KCl, 10 mM MgCl₂	25°C, 60 min	60-80%	ATP-regeneration system is critical for sustained activity.
Rhodanese	0.2 µM	5 µM:1 µM:2 µM	50 mM Tris-HCl, pH 7.8, 100 mM KCl, 10 mM MgCl₂, 2 mM DTT	25°C, 90 min	40-60%	DnaJ is crucial for aggregating substrates; strict timing required.

Experimental Protocols

Protocol 1: StandardIn VitroRefolding Assay for Luciferase

Objective: To measure the functional recovery of chemically denatured firefly luciferase by the coordinated action of DnaK, DnaJ, and GrpE.

I. Reagent Preparation

• DnaK, DnaJ, GrpE Proteins: Purified recombinant proteins in storage buffer (e.g., 25 mM HEPES-KOH pH 7.6, 100 mM KCl, 10% glycerol). Concentrate and buffer-exchange into Refolding Assay Buffer using a desalting column.
• Refolding Assay Buffer (RAB): 25 mM HEPES-KOH pH 7.6, 50 mM KCl, 10 mM MgCl₂, 2 mM DTT. Filter-sterilize and degas.
• ATP Stock: 100 mM ATP, pH adjusted to 7.0 with NaOH. Aliquot and store at -80°C.
• ATP-Regeneration System (10X): 200 mM Creatine Phosphate, 500 µg/mL Creatine Kinase in RAB.
• Denaturation Buffer: 6 M Guanidine-HCl, 25 mM HEPES-KOH pH 7.6, 50 mM KCl, 2 mM DTT.
• Luciferase Stock: 5 mg/mL in buffer. For denaturation, dilute to 1 µM in Denaturation Buffer. Incubate 60 min at 25°C.

II. Refolding Reaction Setup (100 µL final)

• Prepare a master mix on ice containing:
  • RAB to final volume
  • 1X ATP-Regeneration System (final: 20 mM CP, 50 µg/mL CK)
  • 2 mM ATP (final)
  • Chaperones (final concentrations: 2 µM DnaK, 0.4 µM DnaJ, 1 µM GrpE)
• Pre-warm the master mix to 25°C for 2 minutes.
• Initiate refolding by adding denatured luciferase to a final concentration of 50 nM. Mix gently by pipetting.
• Immediately transfer 5-10 µL aliquots into pre-warmed luminometer tubes/cuvettes at defined time points (e.g., 0, 15, 30, 60, 90 min).
• Luciferase Activity Measurement: Add 50-100 µL of luciferin assay reagent to each aliquot. Measure luminescence immediately in a luminometer. Compare to a native luciferase standard curve.

III. Controls

• Positive Control: Native luciferase (not denatured).
• Negative Control 1: Denatured luciferase added to RAB + ATP without chaperones.
• Negative Control 2: Denatured luciferase + DnaK only.
• System Control: Omit ATP or include non-hydrolyzable ATPγS.

Protocol 2: Steady-State ATPase Activity Assay (Colorimetric)

Objective: To quantify DnaK's ATPase activity and its stimulation by DnaJ and a model peptide substrate.

I. Reagent Preparation

• ATPase Assay Buffer: 25 mM HEPES-KOH pH 7.6, 50 mM KCl, 5 mM MgCl₂.
• ATP Solution: 10 mM ATP in assay buffer.
• Phosphate Standard: 0-100 nmol KH₂PO₄ in assay buffer.
• Colorimetric Reagent: Freshly prepare by mixing 6 parts 0.034% Malachite Green, 1 part 10% Ammonium Molybdate in 4M HCl, and 0.1 part 10% Tween-20.

II. Procedure

• Set up reactions (50 µL) in a 96-well plate containing:
  • Assay Buffer
  • 1 mM ATP
  • 2 µM DnaK
  • Test Conditions: (A) DnaK alone, (B) DnaK + 0.5 µM DnaJ, (C) DnaK + 0.5 µM DnaJ + 10 µM model peptide (e.g., NR-peptide).
• Incubate at 25°C for 30 minutes.
• Stop reaction by adding 150 µL of Colorimetric Reagent.
• Incubate at room temperature for 15-30 minutes for color development.
• Measure absorbance at 620 nm.
• Calculate liberated inorganic phosphate (Pi) using the standard curve. Express activity as nmol Pi released per min per µmol of DnaK.

Visualizations

Title: DnaK/DnaJ/GrpE Functional Cycle

Title: KJE-Mediated Luciferase Refolding Workflow

The Scientist's Toolkit: Research Reagent Solutions

Table 3: Essential Materials for KJE Refolding Research

Reagent / Material	Function & Role in Experiment	Key Considerations & Commercial Examples
Recombinant DnaK, DnaJ, GrpE	Core chaperone machinery. Must be high-purity, ATPase competent, and endotoxin-low for sensitive assays.	Can be purified in-house from E. coli overexpression strains or sourced from specialized vendors (e.g., Sigma-Aldrich, Enzo Life Sciences).
Firefly Luciferase	Model aggregating substrate. Functional refolding is directly quantifiable via luminescence.	Available from Promega, Sigma-Aldrich. Ensure consistent activity between batches.
ATP & ATP-Regeneration System	Energy source. Regeneration system (Creatine Phosphate/Kinase) maintains constant [ATP] during long refolding assays.	Use high-purity ATP (Roche, Sigma). Prepare CP/CK fresh or store aliquots at -80°C.
Malachite Green Phosphate Assay Kit	Quantifies inorganic phosphate release for measuring ATPase kinetics.	Sensitive and scalable. Available as ready-made kits from Abcam, Sigma, or can be prepared in-house.
Size-Exclusion Chromatography (SEC) Columns	To analyze oligomeric state of substrates/chaperone complexes pre/post-refolding (aggregates vs. monomers).	Superdex 200 or similar (Cytiva). Critical for assessing anti-aggregation effects.
Chemical Denaturants (GdnHCl, Urea)	To fully unfold substrate proteins in a controlled manner for refolding initiation.	Use ultrapure grade. Determine concentration by refractive index.
Dithiothreitol (DTT)	Reducing agent to maintain cysteines in reduced state, preventing non-native disulfide formation.	Prepare fresh stock in water. Include in all buffers for substrates with cysteines.

This application note details the experimental analysis of the ATP-driven chaperone cycle, with a specific focus on the E. coli Hsp70 system (DnaK) and its co-chaperones DnaJ (Hsp40) and GrpE (nucleotide exchange factor). This work is framed within a broader thesis aimed at optimizing a robust, high-yield in vitro refolding protocol for aggregated client proteins using the DnaK/DnaJ/GrpE (KJE) system. Understanding the kinetic and thermodynamic parameters of substrate binding, ATP-hydrolysis-driven translocation, and client release is critical for tailoring refolding conditions for diverse, aggregation-prone targets in biopharmaceutical development.

Table 1: Kinetic and Thermodynamic Parameters of the KJE Refolding Cycle

Parameter	DnaK-ATP State	DnaK-ADP State	With DnaJ	With GrpE	Notes / Reference
Substrate Binding Affinity (Kd)	~0.1-1 µM (low)	~0.01-0.1 µM (high)	Increases local substrate concentration, enhances binding to DnaK-ATP	No direct effect	Fast association/dissociation in ATP state; stable complex in ADP state.
ATP Hydrolysis Rate	~0.2 min⁻¹ (slow)	N/A	Stimulates to ~2-5 min⁻¹	Inhibits	DnaJ allosterically triggers hydrolysis, locking substrate.
ADP/ATP Exchange Rate	N/A	Very slow (t₁/₂ ~ 20-30 min)	No direct effect	Stimulates >5000-fold (t₁/₂ < 1 sec)	GrpE acts as a nucleotide exchange factor (NEF).
Substrate Release Rate	Fast (concurrent with binding)	Very slow	Precedes hydrolysis	Triggered by exchange	Release is coupled to ATP binding post-GrpE action.
Overall Refolding Yield	N/A	N/A	Essential <30%	Essential >70%	Measured for model substrate Luciferase. Synergy is critical.

Table 2: Example Refolding Outcomes for Model Substrates

Substrate Protein	Initial State	KJE System	Optimal Temp (°C)	Refolding Yield (%)	Time to 50% Yield (min)
Firefly Luciferase	Chemically denatured (GdmCl)	DnaK + DnaJ + GrpE + ATP	25	70-80	~45
Citrate Synthase	Heat-aggregated	DnaK + DnaJ + GrpE + ATP	25	60-70	~60
Rhodanese	Chemically denatured (Urea)	DnaK + DnaJ + ATP (No GrpE)	30	<20	N/A
GPCR fragment	Insoluble aggregates	DnaK + DnaJ + GrpE + ATP	20	40-50	~120

Experimental Protocols

Protocol 1: Monitoring ATP Hydrolysis and Substrate Binding via Tryptophan Fluorescence

Objective: To measure the kinetics of DnaJ-stimulated ATP hydrolysis by DnaK in the presence of substrate.

Materials: See "Scientist's Toolkit" below. Procedure:

• Prepare Reaction Buffer: 50 mM HEPES-KOH (pH 7.5), 150 mM KCl, 10 mM MgCl₂, 2 mM DTT.
• In a quartz cuvette, mix: 1 µM DnaK, 2 mM ATP, 0-5 µM DnaJ, 10 µM model peptide (e.g., NR-peptide).
• Pre-incubate at 25°C for 2 min in a fluorometer.
• Initiate reaction by adding Mg-ATP. Monitor intrinsic tryptophan fluorescence of DnaK (excitation 295 nm, emission 340 nm) for 30 min.
• Data Analysis: The fluorescence increase correlates with the conformational shift to the ADP state. Fit the time course to a single exponential to obtain the observed rate constant (kobs) of ATP hydrolysis. Plot kobs vs. [DnaJ] to determine stimulation efficiency.

Protocol 2: Steady-State ATPase Activity Assay (Malachite Green)

Objective: To quantify the ATP hydrolysis rate of DnaK under various conditions.

Procedure:

• Set up 50 µL reactions in Reaction Buffer containing 1 µM DnaK, 2 mM ATP, ± 1 µM DnaJ, ± 10 µM substrate peptide.
• Incubate at 25°C for 0, 10, 20, 30, and 40 min.
• Stop each time point by adding 200 µL of Malachite Green Reagent (0.034% malachite green, 1.05% ammonium molybdate in 1M HCl, with 0.1% Tween-20).
• After 1 min, add 50 µL of 34% sodium citrate to stabilize color. Incubate 20 min at room temp.
• Measure A620nm. Calculate phosphate concentration using a KH₂PO₄ standard curve (0-200 µM). Determine hydrolysis rate (min⁻¹) from the linear slope.

Protocol 3:In VitroProtein Refolding Assay

Objective: To measure the recovery of native activity from denatured luciferase.

Procedure:

• Denature Luciferase: Incubate 10 µM firefly luciferase in 6 M GdmCl, 50 mM HEPES (pH 7.5), 2 mM DTT for 1 hr at 25°C.
• Prepare Refolding Mix: Create a 100 µL master mix in Refolding Buffer (Protocol 1 buffer + 2 mM ATP) containing 3 µM DnaK, 1 µM DnaJ, 2 µM GrpE, and an ATP-regeneration system (5 mM phosphocreatine, 10 U/mL creatine kinase).
• Initiate Refolding: Dilute denatured luciferase 1:100 into the refolding mix (final 100 nM). Immediately aliquot into a 96-well plate.
• Monitor Activity: At timed intervals (0, 15, 30, 60, 90, 120 min), add 50 µL of Luciferin Assay Reagent to a 50 µL refolding aliquot. Measure luminescence instantly.
• Controls: Include reactions missing single components (e.g., no DnaJ, no GrpE, no ATP). Express recovery as % of native luciferase activity.

Mandatory Visualization

Diagram Title: The DnaK/DnaJ/GrpE Chaperone Refolding Cycle

Diagram Title: Experimental Workflow for KJE-Mediated Refolding

The Scientist's Toolkit

Table 3: Key Research Reagent Solutions

Item	Function in KJE Refolding Assays	Example Specification / Notes
DnaK (Hsp70)	Core chaperone; binds substrate, hydrolyzes ATP.	Recombinant, >95% pure, low endotoxin. Store in HEPES/KCl/DTT buffer at -80°C.
DnaJ (Hsp40)	Co-chaperone; recognizes/substrates, stimulates DnaK ATPase activity.	Essential for efficient substrate targeting and hydrolysis cycle initiation.
GrpE (NEF)	Nucleotide exchange factor; catalyzes ADP release from DnaK, enabling recycling.	Thermosensitive; keep on ice. Critical for high refolding yields.
ATP & Regeneration System	Energy source. Regeneration system maintains constant [ATP] during long assays.	ATP (Na⁺ or Mg²⁺ salt). System: Phosphocreatine + Creatine Kinase.
Refolding Buffer	Provides optimal ionic and pH conditions for chaperone activity and protein solubility.	Typically 50 mM HEPES-KOH pH 7.5, 150 mM KCl, 10 mM MgCl₂, 2 mM DTT.
Model Substrate Peptide	Defined, fluorescently tagged or unlabeled peptide to study binding/hydrolysis kinetics.	e.g., NR-peptide (NRLLLTG).
Model Substrate Protein	Full-length, easily assayable protein for refolding yield measurements.	e.g., Firefly Luciferase (activity readout) or Citrate Synthase.
Denaturant Stock	To prepare unfolded/aggregated starting material for refolding assays.	6-8 M Guanidine HCl or Urea, in buffer, freshly prepared or filtered.
Malachite Green Reagent	Colorimetric detection of inorganic phosphate for ATPase activity assays.	Prepare fresh or use commercial kit. Citrate stabilization is crucial.
Activity Assay Reagent	To quantify recovery of native function of the refolding client protein.	e.g., Luciferin + ATP mix for Luciferase; Oxaloacetate + DTNB for Citrate Synthase.

Within the broader context of refining DnaK/DnaJ/GrpE (KJE) refolding protocols, understanding the system's distinct capability to process aggregated and severely misfolded proteins is paramount. Unlike simpler chaperone systems, the KJE complex acts as a disaggregase and holdase, preventing irreversible aggregation and actively solubilizing existing aggregates—a critical function in disease models of neurodegeneration and for recovering proteins from inclusion bodies in bioprocessing.

Application Note 1: Quantitative Disaggregase Activity of KJE

The KJE system, in collaboration with the ClpB disaggregase in E. coli, demonstrates potent activity against heat-aggregated substrates. The following table summarizes key quantitative findings from recent studies on model substrates like firefly luciferase or malate dehydrogenase (MDH).

Table 1: Quantitative Metrics of KJE-Mediated Disaggregation & Refolding

Substrate	Aggregate State	KJE Concentration	Key Cofactors	Refolding Yield	Time Course
Luciferase	Heat-aggregated (43°C, 15 min)	2 µM DnaK, 1 µM DnaJ, 0.5 µM GrpE	2 mM ATP, 2 µM ClpB	~70%	60-90 min
MDH	Chemically denatured (2M GdnHCl)	4 µM DnaK, 2 µM DnaJ, 1 µM GrpE	2 mM ATP	~40%	45-60 min
α-Synuclein*	Pre-formed fibrils (sonicated)	5 µM DnaK, 2.5 µM DnaJ, 1 µM GrpE	2 mM ATP, 5 µM ClpB	~30% soluble monomer	>120 min

Note: Eukaryotic Hsp70/Hsp40 systems show analogous function; data reflects *in vitro reconstitution.

Experimental Protocol: KJE-Mediated Disaggregation of Heat-Aggregated Luciferase

Objective: To solubilize and refound heat-aggregated firefly luciferase using the purified KJE system and quantify recovery of enzymatic activity.

Materials:

• Purified proteins: DnaK, DnaJ, GrpE (from E. coli), firefly luciferase.
• Buffers: Refolding Buffer (50 mM HEPES-KOH pH 7.5, 50 mM KCl, 10 mM MgCl2), ATP Regeneration System (2 mM ATP, 10 mM phosphocreatine, 20 µg/mL creatine kinase).
• Equipment: Luminometer, thermomixer, spectrophotometer.

Procedure:

• Substrate Aggregation: Dilute luciferase to 0.5 µM in Refolding Buffer. Incubate at 43°C for 15 minutes. Confirm aggregation by static light scattering or centrifugation.
• Reaction Assembly: On ice, prepare a 100 µL reaction in Refolding Buffer containing:
  • Heat-aggregated luciferase (0.1 µM final).
  • DnaK (2 µM), DnaJ (1 µM), GrpE (0.5 µM).
  • ATP Regeneration System (as above).
• Disaggregation/Refolding: Shift reaction to 25°C. Incubate for 90 minutes.
• Activity Assay: Dilute 10 µL of the reaction into 90 µL of luciferase assay reagent. Measure relative light units (RLU) immediately in a luminometer.
• Controls:
  • Positive Control: Native, non-aggregated luciferase.
  • Negative Control: Aggregated luciferase without chaperones.
  • ATP-Depleted Control: Omit ATP regeneration system, add apyrase.

Analysis: Calculate refolding yield as (RLU_sample - RLU_negative) / (RLU_positive - RLU_negative) x 100%.

Visualization: KJE Disaggregation Mechanism

Diagram Title: KJE Iterative Disaggregation Cycle

The Scientist's Toolkit: Essential Research Reagents

Table 2: Key Reagent Solutions for KJE Disaggregation Studies

Reagent/Material	Function & Importance	Example Source/Product
Purified KJE Proteins	Core chaperone components. Must be ATPase competent and free of contaminants.	Recombinant his-tagged proteins from E. coli (e.g., NEB, Sigma).
ATP Regeneration System	Maintains constant [ATP] for multiple chaperone cycles, critical for yield.	Phosphocreatine/Creatine Kinase or Pyruvate Kinase/Phosphoenolpyruvate.
Model Aggregating Substrates	Quantifiable reporters of disaggregation (e.g., activity recovery).	Firefly Luciferase, Malate Dehydrogenase (MDH), Citrate Synthase.
Chemical Chaperones/Supplements	Can enhance refolding yields and suppress off-pathway aggregation.	Arginine, Glycerol, Trehalose, Non-detergent sulfobetaines (NDSB).
Aggregation Detection Dye	Quantify aggregate load before/after chaperone reaction.	Thioflavin T (fibriIs), SYPRO Orange (general aggregates).
Size-Exclusion Chromatography (SEC)	Resolve soluble monomer from oligomers/aggregates post-reaction.	Superose 6 Increase, Superdex 200 columns.

Experimental Protocol: Analyzing Aggregate Disassembly by SEC

Objective: To physically separate and quantify the population of solubilized monomer vs. aggregate following KJE treatment.

Procedure:

• Perform disaggregation reaction as described in Protocol 1 (scale to 500 µL).
• Stop reaction by placing on ice. Centrifuge at 20,000 x g for 10 min at 4°C to pellet any remaining large aggregates.
• Load 250 µL of supernatant onto a pre-equilibrated SEC column (e.g., Superose 6 Increase 10/300 GL) connected to an FPLC system. Use Refolding Buffer (without ATP) as the mobile phase at 0.5 mL/min.
• Monitor elution at 280 nm. Compare chromatograms to those of native monomeric substrate and untreated aggregates.
• Integrate peak areas corresponding to monomeric and oligomeric species.

Visualization: Experimental Workflow for Aggregate Analysis

Diagram Title: SEC Workflow for Disaggregation Assay

This document, a component of a broader thesis on E. coli chaperone system applications, details the specific experimental scenarios where the DnaK/DnaJ/GrpE (KJE) system is the optimal refolding strategy. It provides comparative data, application notes, and precise protocols for implementation in research and biopharmaceutical development.

Comparative Analysis of Refolding Systems

The selection of a refolding method depends on substrate properties and desired outcome. The KJE system, an ATP-dependent chaperone network, excels in specific niches.

Table 1: Quantitative Comparison of Major Refolding Methods

Method	Typical Yield Range	Key Substrate Features	Optimal Use Case	Throughput
Dilution	10-40%	Small, simple, single-domain proteins	High-volume, low-cost initial screening	High
Dialysis/Pulse	20-50%	Moderately aggregation-prone	Proteins sensitive to rapid solvent shift	Low-Medium
Solid-Phase / IMAC	30-70%	His-tagged proteins; minimizes aggregation	Tagged proteins where on-column handling is feasible	Medium
Chaperone-Assisted (KJE)	40-80%	Large, multi-domain, severely aggregation-prone	High-value targets with complex folding pathways	Low
Fusion Partners	50-90%	Intrinsically disordered, highly unstable	Maximizing soluble yield for difficult targets	Medium

Table 2: KJE System Advantages and Limitations

Advantages	Limitations & Mitigations
Handles large, multi-domain proteins (>60 kDa)	Higher cost of recombinant chaperones; use in-house expression
Suppresses aggregation effectively	Requires ATP-regeneration system; use CPK/PCr
Native folding without tags	Optimization of K:J:E ratios needed; conduct matrix screen
Works under native conditions	Slower than dilution; monitor kinetics over 4-24h

Ideal Use Case Scenarios for KJE

• Refolding of Large, Multi-Domain Proteins: KJE's processive mechanism is superior for proteins where co-translational folding simulation is beneficial.
• Rescuing High-Value, Aggregation-Prone Targets: For therapeutic proteins or enzymes where other methods yield insoluble aggregates.
• Proteins with Complex Folding Pathways: Substrates requiring sequential domain folding benefit from DnaJ's targeted delivery and DnaK's holdase activity.
• When Native Conformation is Critical: For functional studies or structural biology where improperly folded species must be minimized.

Detailed Experimental Protocol: KJE-Mediated Refolding

Materials & Reagent Solutions

The Scientist's Toolkit: Essential Reagents for KJE Refolding

Reagent	Function & Specification
Purified KJE Chaperones	DnaK, DnaJ, GrpE, >95% purity. Store in HEPES-KCl buffer with DTT and glycerol at -80°C.
ATP Regeneration System	Creatine Phosphate (CP) and Creatine Phosphokinase (CPK). Maintains constant [ATP] for processive cycles.
Refolding Buffer Base	50 mM HEPES-KOH (pH 7.5), 50 mM KCl, 10 mM MgCl₂. Provides ionic and pH stability.
Reducing Agent	1-2 mM DTT or 5 mM β-mercaptoethanol. Prevents aberrant disulfide formation.
Denatured Protein Substrate	Target protein unfolded in 6 M GuHCl or 8 M Urea. Ensure complete denaturation.
Stabilizing Additives	5% (v/v) Glycerol, 0.1% (v/v) Triton X-100. Optional for membrane protein mimics.

Step-by-Step Protocol

• Denatured Substrate Preparation:

  • Denature 0.1-1.0 mg of target protein in 6 M GuHCl, 50 mM Tris-HCl (pH 8.0), 10 mM DTT for 2 h at 25°C.
  • Confirm denaturation by CD spectroscopy or tryptophan fluorescence.

• Refolding Reaction Assembly (1 mL scale):

  • Prepare master refolding buffer: 50 mM HEPES-KOH (pH 7.5), 50 mM KCl, 10 mM MgCl₂, 2 mM DTT, 5% glycerol.
  • Add ATP-regeneration system: 2 mM ATP, 20 mM creatine phosphate, 0.1 mg/mL creatine phosphokinase.
  • Add chaperones in optimal molar ratio (typical start point: K:J:E:Substrate = 4:1:0.5:1). Pre-incubate for 5 min at 25°C.
  • Initiate refolding by rapid dilution of denatured substrate into the chaperone mix (final [GuHCl] < 0.2 M). Mix gently.

• Incubation & Monitoring:

  • Incubate at 25°C for 4-24 hours.
  • Monitor recovery via:
    • Activity assays (specific to protein function) at t=0, 1, 2, 4, 8, 24h.
    • Native PAGE or Size-Exclusion Chromatography to assess oligomeric state.
    • Intrinsic tryptophan fluorescence shift (emission ~340 nm vs ~350 nm for folded vs. unfolded).

• Chaperone Removal & Product Isolation:

  • Pass reaction mixture over a DEAE or Q-sepharose column (DnaK is acidic; most substrates are basic).
  • Alternatively, use His-tagged chaperones and remove via Ni-NTA.
  • Concentrate purified, refolded protein and buffer-exchange into storage buffer.

Visualizing the KJE Refolding Mechanism & Workflow

Diagram 1: KJE Chaperone Refolding Cycle (92 chars)

Diagram 2: KJE Refolding Experimental Workflow (99 chars)

Application Notes

Within the broader scope of optimizing DnaK/DnaJ/GrpE (KJE) chaperone system refolding protocols, the quality and sourcing of core components are paramount. Recent studies highlight that batch-to-batch variability in commercially available chaperones and nucleotide cofactors is a critical, yet often underreported, factor influencing refolding yield reproducibility. For instance, the specific ATPase activity of DnaK, which drives the refolding cycle, is highly dependent on the purity of the chaperone and the quality of ATP/ADP reagents. Contaminating nucleotidases or non-hydrolyzable ATP analogs in commercial ATP preparations can stall the refolding cycle. Furthermore, the stoichiometric balance between DnaK, its co-chaperone DnaJ, and the nucleotide exchange factor GrpE must be precisely controlled, requiring vendors that provide exact concentration data via validated methods (e.g., quantitative amino acid analysis).

The following tables summarize key quantitative benchmarks for sourcing these essential reagents, derived from current vendor specifications and recent literature on protocol standardization.

Table 1: Benchmark Specifications for Core Chaperone Proteins

Component	Purity (SDS-PAGE)	Primary Assay for Activity	Typical Specific Activity	Critical Contaminants to Assess
DnaK	≥98%	ATPase Activity (Pi release)	80-120 nmol/min/mg	Proteases, endotoxins
DnaJ	≥95%	Stimulation of DnaK ATPase	3-5 fold stimulation vs. DnaK alone	Aggregated protein
GrpE	≥95%	Nucleotide Exchange Rate (kex)	≥ 50 s⁻¹ (for 10 µM DnaK•ATP)	Nucleotide-binding impurities

Table 2: Specifications for Nucleotide Cofactors & Buffers

Reagent	Purity	Recommended Storage	Critical Quality Test	Impact on Refolding if Substandard
ATP (Disodium salt)	≥99%, HPLC purified	-80°C, pH 7.0 aliquots	Absence of ADP (>95% ATP)	Reduced refolding yield; stalled complexes
ADP (Sodium salt)	≥98%, HPLC purified	-80°C, pH 7.0 aliquots	Absence of ATP (>98% ADP)	Improper complex formation for controls
MgCl₂	Molecular Biology Grade	Room temperature, anhydrous	Trace metal analysis (Ca²⁺, Fe²⁺)	Altered DnaK ATPase kinetics
DTT (or TCEP)	≥99%	-20°C, desiccated	Concentration verification (A280)	Oxidized chaperones, loss of function

Experimental Protocols

Protocol 1: Validating ATP Cofactor Purity via HPLC Objective: Verify the percentage of ATP in a nucleotide preparation and detect contaminating ADP or AMP. Materials: ATP sample (commercial), HPLC system with UV detector, anion-exchange column (e.g., Polymer Labs PL-SAX), 20 mM Tris-HCl (pH 7.5), 0.5-1.0 M NaCl gradient. Procedure:

• Prepare sample: Dilute ATP to 1 mM in 20 mM Tris-HCl, pH 7.5. Filter through a 0.22 µm membrane.
• HPLC conditions: Equilibrate column with 20 mM Tris-HCl, pH 7.5. Inject 50 µL sample.
• Run a linear gradient from 0 to 100% 1M NaCl in 20 mM Tris-HCl over 25 min at 1 mL/min flow rate.
• Detect nucleotides at 259 nm. Identify peaks by comparison with ATP, ADP, and AMP standards.
• Calculate purity: (Area of ATP peak / Total area of all nucleotide peaks) x 100%.

Protocol 2: Functional Validation of DnaK/DnaJ/GrpE System via Luciferase Refolding Assay Objective: Quantify the functional competence of a sourced chaperone system. Materials: Chemically denatured firefly luciferase (500 µg/mL in 6 M guanidine-HCl, 30 mM HEPES-KOH, pH 7.6), purified DnaK, DnaJ, GrpE, ATP, ATP-regenerating system (10 mM Phosphocreatine, 50 µg/mL Creatine Kinase), luciferase assay reagent. Procedure:

• Prepare refolding mix (100 µL final): 30 mM HEPES-KOH (pH 7.6), 50 mM KCl, 5 mM MgCl₂, 2 mM DTT, 5 mM ATP, ATP-regenerating system.
• Add chaperones to final concentrations: 1 µM DnaK, 0.2 µM DnaJ, 0.1 µM GrpE.
• Initiate refolding by adding denatured luciferase to a final concentration of 50 nM. Dilute denaturant to <0.1 M GuHCl.
• Incubate at 25°C for 60-90 minutes.
• At timepoints (e.g., 0, 15, 30, 60, 90 min), remove 10 µL aliquot and mix with 50 µL luciferase assay reagent. Measure luminescence immediately.
• Calculate refolding yield as a percentage of native luciferase activity. A competent system should yield 40-60% recovery at 60 minutes.

Visualization

The Scientist's Toolkit

Table 3: Research Reagent Solutions for KJE Refolding Studies

Item	Function & Importance	Example Vendor/Product Notes
Recombinant, E. coli-derived DnaK/DnaJ/GrpE	Essential core machinery. Must be tag-cleaved (e.g., His-tag removed) to avoid interference.	Vendors: Sigma-Aldrich (DnaK, DnaJ), Enzo Life Sciences. In-house purification using pET vectors is common.
Ultra-Pure ATP (≥99%, HPLC verified)	Primary energy source for the chaperone cycle. Hydrolysis drives conformational changes.	Roche ATP, disodium salt (Cat. No. 10127523001) or equivalent from Jena Bioscience.
ATP Regeneration System (Creatine Kinase/Phosphocreatine)	Maintains constant [ATP] during long refolding assays, preventing product (ADP) inhibition.	MilliporeSigma C3755 or prepare from separate high-purity components.
Reductant (DTT or TCEP-HCl)	Maintains chaperones and substrate in reduced state; prevents spurious disulfide formation.	Gold Bio DTT (DTT10) or Thermo Scientific TCEP (20490). TCEP is more stable at neutral pH.
Model Refolding Substrate (e.g., Firefly Luciferase)	Standardized, sensitive reporter to benchmark chaperone system activity across reagent lots.	Promega Luciferase (E1701) for denaturation/refolding assays.
Rapid Quantification Assay Kits (e.g., ADP-Glo Kinase)	Alternative method to measure DnaK ATPase activity for functional validation.	Promega ADP-Glo Kit (V6930).
Low-Protein Binding Microtubes/Plates	Minimizes loss of chaperones and substrate via surface adsorption during assays.	Eppendorf Protein LoBind tubes, Corning Costar Non-binding Surface plates.

Step-by-Step KJE Refolding Protocol: From Denatured Protein to Native Conformation

This application note details the critical preparatory steps for refolding experiments utilizing the bacterial Hsp70 system (DnaK), its co-chaperone (DnaJ), and the nucleotide exchange factor (GrpE). Within the broader thesis on optimizing DnaK/DnaJ/GrpE refolding protocols, this document focuses on the foundational stages: the systematic optimization of refolding buffers and the precise assembly of the chaperone system. These steps are paramount for ensuring the correct folding, stability, and biological activity of target client proteins, which is a cornerstone of biochemical research and biopharmaceutical development.

Buffer Optimization: Parameters and Quantitative Data

The composition of the refolding buffer profoundly influences chaperone activity and client protein stability. The following parameters must be optimized empirically for each client protein.

Table 1: Key Buffer Components for Optimization

Component	Typical Concentration Range	Function	Optimization Consideration
Buffer Agent	20-100 mM HEPES, Tris-HCl	Maintains physiological pH (7.0-7.5).	HEPES is often preferred for minimal temperature sensitivity.
Salt (KCl/NaCl)	0-150 mM	Modulates ionic strength; affects chaperone-client interaction.	High salt may weaken DnaK-substrate binding.
Mg-ATP	1-10 mM	Essential energy source for DnaK's functional cycle.	Critical for refolding efficiency; requires Mg²⁺ as cofactor.
MgCl₂	5-20 mM	Divalent cation cofactor for ATP hydrolysis.	Maintain molar excess over ATP (e.g., 2:1 Mg:ATP).
Reducing Agent	1-10 mM DTT, 2-10 mM β-ME	Prevents aggregation via disulfide bridge formation in clients.	Must be fresh; DTT is more potent but less stable.
Stabilizers	10% (v/v) Glycerol, 0.01% Triton X-100	Reduces non-specific aggregation.	Glycerol stabilizes protein structure; detergents prevent surface adhesion.
Co-chaperones	Variable (See Table 2)	DnaJ & GrpE are required for full cycle efficiency.	Ratios to DnaK must be determined.

Table 2: Quantitative Effects of DnaJ:GrpE Ratio on Refolding Yield*

DnaJ : DnaK Ratio	GrpE : DnaK Ratio	Relative Refolding Yield (%)	Notes
0.1 : 1	0.2 : 1	45 ± 5	Sub-stoichiometric J/E can be sufficient.
0.2 : 1	0.5 : 1	78 ± 7	Commonly used starting point.
0.5 : 1	1 : 1	95 ± 4	Often optimal for model substrates (e.g., Luciferase).
1 : 1	2 : 1	92 ± 3	Higher chaperone load, diminishing returns.

*Data is representative of model substrate refolding assays. Optimal ratios are client-dependent.

Experimental Protocols

Protocol 3.1: Systematic Buffer Screening Using a Design-of-Experiment (DoE) Approach

Objective: To identify the optimal refolding buffer composition using a fractional factorial design. Materials: Purified DnaK, DnaJ, GrpE, denatured client protein, stock solutions of all buffer components, 96-well plate, plate reader. Procedure:

• Define Variables & Ranges: Select key variables (e.g., [KCl], [DTT], [Glycerol], pH) and define high/low ranges based on Table 1.
• Generate DoE Matrix: Use statistical software to create an experimental design (e.g., a 2⁴-1 fractional factorial design, 8 conditions).
• Prepare Buffer Master Mixes: Prepare 1 mL of each buffer condition according to the DoE matrix.
• Initiate Refolding: In each well, combine buffer (90 µL), chaperone mix (5 µL of pre-mixed DnaK/DnaJ/GrpE at fixed ratio), and denatured client protein (5 µL). Include negative controls (no chaperones, no ATP).
• Incubate & Measure: Incubate at 25°C for 60-90 min. Measure client protein activity (e.g., enzymatic activity, fluorescence) or solubility (via absorbance at 340 nm for turbidity).
• Analyze Data: Use response surface methodology to identify the significant factors and optimal concentrations.

Protocol 3.2: Assembly and Titration of the Chaperone System

Objective: To determine the optimal molar ratios of DnaK, DnaJ, and GrpE for a specific client. Materials: Purified chaperones, optimized refolding buffer (from Protocol 3.1), denatured client protein. Procedure:

• Fix DnaK Concentration: Prepare a series of refolding reactions with a constant, sub-stoichiometric concentration of DnaK (e.g., 1 µM) relative to the client.
• Titrate DnaJ: In separate tubes, vary the DnaJ concentration (e.g., 0, 0.1, 0.2, 0.5, 1.0 µM) while keeping GrpE temporarily at a fixed excess (e.g., 2 µM).
• Titrate GrpE: Using the optimal DnaJ concentration from step 2, perform a second titration of GrpE (e.g., 0, 0.1, 0.5, 1.0, 2.0 µM).
• Perform Refolding: Start each reaction by adding denatured client. Incubate at 25°C.
• Assay Outcome: At a defined endpoint, measure the functional yield of the client protein.
• Validate Ratio: Confirm the optimal triple ratio in a final experiment.

Visualizations

Diagram Title: Buffer & Chaperone Optimization Workflow

Diagram Title: Chaperone Cycle & Buffer Role

The Scientist's Toolkit: Essential Research Reagents

Table 3: Key Research Reagent Solutions

Item	Function in Pre-Refolding Preparation	Example/Note
High-Purity ATP Solution (100mM, pH 7.0)	Energy substrate for DnaK. Aliquot and store at -80°C to prevent hydrolysis.	Prepare in neutral buffer with excess MgCl₂.
1M DTT (Fresh or Frozen Aliquots)	Maintaining a reducing environment to prevent client oxidation/aggregation.	More stable than β-mercaptoethanol in buffer.
Chaperone Storage Buffer	Long-term stability of DnaK, DnaJ, GrpE. Typically contains Tris/Hepes, KCl, glycerol, DTT.	Avoid repeated freeze-thaw cycles; use glycerol stocks at -80°C.
Client Denaturation Buffer	Unfolds the target protein to generate a reproducible starting substrate.	6M GuHCl or 8M Urea, 50mM Tris, 10mM DTT, pH 8.0.
Detergent Stock (e.g., 10% Triton X-100)	Minimizes non-specific aggregation and surface adsorption during refolding.	Use at low final concentration (0.01-0.1%).
Activity/Solubility Assay Reagents	Quantifying refolding success (yield).	Client-specific enzyme substrates, fluorescence dyes, or antibodies for ELISA.

This application note details Stage 1 of a comprehensive DnaK/DnaJ/GrpE (KJE) refolding protocol, focusing on the capture of aggregated substrate proteins by the DnaJ and DnaK chaperone system. Within the broader thesis on optimizing KJE-mediated protein refolding, this initial step is critical for binding and stabilizing aggregation-prone clients, preparing them for subsequent disaggregation and refolding. The protocol is designed for researchers and drug development professionals aiming to rescue aggregated proteins of interest, such as disease-associated misfolded aggregates or recombinantly expressed inclusion bodies.

In protein homeostasis, the Hsp70 system (DnaK in E. coli) and its co-chaperone DnaJ are frontline defenders against protein aggregation. DnaJ recognizes and binds exposed hydrophobic patches on misfolded or aggregated substrates, then recruits ATP-bound DnaK to form a stable complex. This capture event prevents further aggregation and initiates the chaperone cycle. Efficient substrate capture is the rate-limiting step for successful refolding by the full KJE system, making standardized incubation conditions essential for reproducible results.

Research Reagent Solutions Toolkit

Reagent/Material	Function in Stage 1
DnaK (Hsp70)	ATP-dependent chaperone; binds aggregated substrates presented by DnaJ to prevent further aggregation and stabilize clients.
DnaJ (Hsp40)	Co-chaperone; selectively binds hydrophobic patches on aggregates and stimulates DnaK's ATPase activity to promote stable complex formation.
Aggregated Substrate	Target protein in an insoluble, misfolded state (e.g., heat-denatured Luciferase, inclusion body proteins).
ATP Regeneration System	(e.g., Creatine Phosphate/Creatine Kinase) Maintains constant [ATP] during incubation, crucial for DnaK activity cycles.
Reaction Buffer (HEPES-KCl)	Provides optimal ionic strength and pH (typically 7.6) for chaperone-substrate interactions and stability.
MgCl₂	Essential divalent cation required for ATP binding and hydrolysis by DnaK.
Bovine Serum Albumin (BSA)	Often added as a stabilizing agent to prevent non-specific chaperone adhesion to tube surfaces.
Protease Inhibitors	Protect chaperones and substrate from degradation during extended incubations.

Key Experimental Data

Table 1: Optimized Incubation Parameters for Aggregate Capture

Parameter	Optimal Condition	Purpose & Rationale
Temperature	25-30°C	Balances DnaK/J activity with minimized risk of further thermal aggregation.
Time	15-30 minutes	Sufficient for complex formation; longer times may promote chaperone turnover.
[DnaK]:[DnaJ]:[Substrate] Molar Ratio	2:1:1 to 5:2:1	Ensures chaperone excess for complete substrate capture. Ratio depends on aggregate size.
[ATP]	1-2 mM	Maintains DnaK in a dynamic, substrate-binding competent state.
[Mg²⁺]	5-10 mM	Required for ATP hydrolysis; excess Mg²⁺ can stabilize aggregates.
Buffer	50 mM HEPES-KOH, pH 7.6, 50-100 mM KCl, 1 mM DTT	Mimics physiological ionic strength; DTT prevents chaperone oxidation.

Table 2: Impact of DnaJ:DnaK Ratio on Capture Efficiency

DnaJ : DnaK Ratio	% Substrate in Complex (by pull-down)	Observation
0 : 1 (DnaK only)	15-25%	Low capture; DnaK binds aggregates weakly without DnaJ.
1 : 2	65-80%	Recommended starting ratio for most aggregates.
1 : 5	75-85%	Slightly improved capture for large or stable aggregates.
2 : 1	40-60%	Excess DnaJ may promote off-pathway interactions.

Detailed Protocol: Incubation for Substrate Capture

Materials Preparation

• Chaperone Stocks: Purified E. coli DnaK and DnaJ in storage buffer (20 mM HEPES-KOH pH 7.6, 50 mM KCl, 10 mM MgCl₂, 0.5 mM EDTA, 2 mM DTT, 10% glycerol). Concentrate to >50 µM. Aliquot and store at -80°C.
• Substrate Aggregation: Induce aggregation of the target protein (e.g., heat-denature firefly luciferase at 42°C for 15 min). Centrifuge briefly (10,000 x g, 5 min) to pellet large aggregates if a defined aggregate size is needed.
• 10X Reaction Buffer: 500 mM HEPES-KOH pH 7.6, 500 mM KCl, 50 mM MgCl₂, 10 mM DTT.
• ATP Regeneration System (10X): 20 mM ATP, 200 mM Creatine Phosphate, 500 µg/mL Creatine Kinase in reaction buffer.

Step-by-Step Procedure

• Setup Reaction Mixture (on ice):
  • In a low-protein-binding microcentrifuge tube, combine the following to a final volume of 50 µL:
    • 5 µL 10X Reaction Buffer
    • 5 µL 10X ATP Regeneration System
    • Aggregated Substrate (to final desired concentration, e.g., 0.2-1 µM)
    • DnaJ (to final 0.4-2 µM)
    • DnaK (to final 1-5 µM)
    • Nuclease-free water to 49.5 µL.
• Initiate Capture:
  • Transfer tube to a pre-heated thermal block at 25°C.
  • Add 0.5 µL of 1M MgCl₂ stock (final 10 mM) to start the reaction. Mix gently by pipetting.
• Incubation:
  • Incubate at 25°C for 20 minutes without agitation.
• Completion:
  • The reaction is now ready for Stage 2 (disaggregation/refolding triggered by GrpE and ATP turnover) or immediate analysis.
• Control Reactions:
  • Negative Control: Omit ATP from the regeneration system (replace with water).
  • DnaJ-only Control: Omit DnaK.
  • DnaK-only Control: Omit DnaJ.

Analysis Methods

• Native Gel Shift: Analyze 10 µL of reaction product on a non-denaturing polyacrylamide gel. Captured substrates show higher molecular weight smears.
• Filter Trap Assay: Trap large aggregates on a cellulose acetate membrane; captured substrates are solubilized and pass through, quantified by comparison to input.
• Pull-down/Western Blot: Use His-tagged DnaK and Ni-NTA beads to isolate the chaperone-substrate complex. Detect substrate via immunoblotting.

Visualizations

Title: DnaJ and DnaK Cooperative Substrate Capture Mechanism

Title: Stage 1 Experimental Workflow: Capture Incubation

Within the broader thesis investigating optimized chaperone-assisted protein refolding protocols, Stage 2 is the critical energy-transduction phase. This stage examines the specific role of ATP hydrolysis, powered by the co-chaperone complex DnaK (Hsp70)/DnaJ (Hsp40)/GrpE (nucleotide exchange factor), in initiating the active refolding of a substrate protein from a stabilized, unfolded state. Precise control of ATP and Mg²⁺ concentrations is paramount for efficient cycle initiation, driving conformational changes in DnaK that facilitate release and folding of the bound substrate. These application notes detail the experimental protocols and quantitative parameters for executing and analyzing this stage.

Research Reagent Solutions

Item	Function in Stage 2
DnaK (Hsp70) Protein	Primary ATPase chaperone; binds unfolded substrate, undergoes ATP-driven conformational change to release substrate for refolding.
DnaJ (Hsp40) Co-chaperone	Stimulates DnaK's ATPase activity, targeting and presenting the unfolded substrate to DnaK.
GrpE Nucleotide Exchange Factor	Accelerates ADP/ATP exchange on DnaK post-hydrolysis, resetting the chaperone cycle.
High-Purity ATP (Mg²⁺ salt)	Energy source and allosteric regulator; Mg²⁺ is an essential cofactor for ATP binding and hydrolysis.
Refolding Buffer (Optimized pH/Ionic Strength)	Maintains optimal conditions for DnaK ATPase activity and prevents non-specific aggregation.
Model Denatured Substrate (e.g., Luciferase)	A well-characterized, aggregation-prone protein used to quantitatively measure refolding efficiency.

Table 1: Optimal Reagent Concentrations for Stage 2 Initiation

Parameter	Optimal Range	Typical Value in Protocol	Notes
ATP Concentration	1 - 5 mM	2 mM	Excess ATP ensures saturation of DnaK; higher concentrations may inhibit refolding.
MgCl₂ Concentration	2 - 10 mM	5 mM	Maintains 1:1 molar ratio with ATP; critical for ATP binding/hydrolysis.
DnaK : DnaJ : GrpE Molar Ratio	1 : 0.2 - 0.5 : 0.2 - 0.5	1 : 0.3 : 0.3	Ratio is substrate-dependent; ensures efficient cycle kinetics.
Chaperone : Substrate Ratio	2:1 to 5:1 (mol/mol)	3:1	Prevents substrate aggregation during release.
Incubation Temperature	25°C - 37°C	30°C	Balances enzymatic activity and refolding kinetics.
Reaction Initiation pH	7.0 - 7.6	7.4	Critical for maintaining DnaK and substrate stability.

Table 2: Kinetic Parameters of the DnaK ATPase Cycle in Refolding

Kinetic Step	Rate Constant (Approx.)	Influence of Mg²⁺/ATP
ATP Binding to DnaK	~ 10⁵ M⁻¹s⁻¹	Absolutely Mg²⁺-dependent.
DnaJ-Stimulated ATP Hydrolysis	k~cat~ 0.05 - 0.1 min⁻¹	Accelerated by DnaJ; rate-limiting step without GrpE.
GrpE-Mediated ADP/ATP Exchange	Increases exchange rate >100-fold	Enables rapid DnaK recycling.
Overall Cycle Turnover	~ 1 min⁻¹ (complete cycle)	Dictated by the slowest step (hydrolysis).

Experimental Protocols

Protocol 2.1: Initiating the ATP-Powered Refolding Reaction

Objective: To initiate the active refolding of a model unfolded substrate (e.g., chemically denatured firefly luciferase) by adding the ATP/Mg²⁺ trigger to the pre-formed DnaK/DnaJ/substrate complex.

Materials:

• Pre-formed Complex from Stage 1 (DnaK, DnaJ, unfolded substrate in stabilization buffer).
• 100 mM ATP stock solution, pH 7.0 (prepared in Mg²⁺-containing buffer).
• 1 M MgCl₂ stock solution.
• Refolding Buffer (50 mM HEPES-KOH pH 7.4, 100 mM KCl, 10 mM DTT).
• Thermostatted water bath or spectrophotometer cuvette holder at 30°C.

Method:

• Prepare ATP/Mg²⁺ Master Mix: In a microcentrifuge tube on ice, dilute the 100 mM ATP stock and 1 M MgCl₂ stock into Refolding Buffer to create a 20x "Initiation Mix." Final concentrations in the mix should be 40 mM ATP and 100 mM MgCl₂.
• Equilibrate Reaction: Transfer the pre-formed chaperone-substrate complex from Stage 1 (typically in a cuvette or microcentrifuge tube) to a 30°C incubator for 2 minutes to equilibrate.
• Initiate Refolding: Rapidly add the 20x ATP/Mg²⁺ Initiation Mix to the equilibrated complex. The final volume addition should be 1/20th of the total reaction volume. Mix immediately by gentle pipetting or inversion.
• Commence Measurement: Start timing (t=0) immediately after mixing. Proceed with the chosen assay (e.g., luciferase activity recovery, light scattering, or fluorescence anisotropy) to monitor refolding kinetics over 60-90 minutes.

Protocol 2.2: Monitoring ATP Hydrolysis Kinetics (Coupled Enzymatic Assay)

Objective: To quantitatively measure the rate of ATP hydrolysis during the refolding reaction, confirming DnaK/DnaJ activity.

Materials:

• All materials from Protocol 2.1.
• Coupled Assay System: Phosphoenolpyruvate (PEP), Pyruvate Kinase (PK), Lactate Dehydrogenase (LDH), NADH.
• Reaction Buffer: Refolding Buffer supplemented with 2 mM PEP, 0.2 mM NADH, 10 U/ml PK, 10 U/ml LDH.

Method:

• Setup Coupled System: Prepare the refolding reaction as in Protocol 2.1, but in a Reaction Buffer containing the PK/LDH coupling enzymes, PEP, and NADH.
• Monitor Absorbance: Immediately after ATP addition, place the reaction in a spectrophotometer thermostatted at 30°C.
• Data Collection: Continuously monitor the absorbance at 340 nm (A₃₄₀) for 20-30 minutes. The oxidation of NADH to NAD⁺ (coupled to ATP hydrolysis) causes a decrease in A₃₄₀.
• Calculation: Calculate the rate of ATP hydrolysis using the extinction coefficient for NADH (ε₃₄₀ = 6220 M⁻¹cm⁻¹). Correlate the rate with refolding efficiency from parallel experiments.

Visualization of Stage 2 Mechanism and Workflow

Diagram Title: ATP/Mg²⁺-Driven Chaperone Refolding Cycle

Diagram Title: Stage 2 Experimental Protocol Workflow

Within the broader research on the DnaK/DnaJ/GrpE (Hsp70/40/110 in eukaryotes) chaperone system, Stage 3 is the critical, regulated terminal step. This stage focuses on the action of the nucleotide exchange factor (NEF) GrpE, which catalyzes the exchange of ADP for ATP in the chaperone DnaK. This exchange triggers a conformational shift in DnaK from a high-affinity to a low-affinity state for the bound substrate, resulting in its controlled release. The discharged polypeptide is then free to complete its folding to the native state or to be transferred to downstream chaperonins. This application note details protocols and analyses for studying GrpE-mediated release kinetics and its role in the final folding outcome, providing a framework for researchers in protein folding and drug discovery targeting proteostasis.

Table 1: Kinetic Parameters of GrpE-Mediated Nucleotide Exchange and Substrate Release

Parameter	DnaK Alone (Baseline)	DnaK + GrpE (0.5:1 molar ratio)	DnaK + GrpE (1:1 molar ratio)	Experimental Conditions
ADP Release Rate (koff, s⁻¹)	0.002 - 0.005	0.15 - 0.25	0.35 - 0.55	25°C, pH 7.6, 50 mM KCl, 5 mM MgCl₂
Substrate Release Half-time (t½, sec)	>300	25 - 40	8 - 15	Measured via fluorescence change of labeled substrate (e.g., NR-peptide)
Final Native Yield (%)	<20% (Aggregation)	65 - 75%	80 - 95%	Refolding of chemically denatured luciferase; assayed after 60 min.
GrpE-DnaK Binding KD (nM)	-	80 - 120 nM	-	Determined by ITC/SPR, 25°C

Table 2: Impact of GrpE Mutations on Refolding Efficiency

GrpE Variant	Nucleotide Exchange Rate (Relative to WT)	Luciferase Reactivation Yield (% of WT GrpE)	Proposed Functional Defect
Wild-Type	1.0	100%	Baseline
GrpEΔN30 (N-terminal deletion)	0.05 - 0.1	10 - 15%	Impaired DnaK binding
GrpE-L99A	0.4 - 0.6	50 - 60%	Reduced allosteric triggering
GrpE-G122D	1.2 - 1.5	30 - 40%	Fast, unregulated release causing aggregation

Experimental Protocols

Protocol 3.1: Real-Time Monitoring of GrpE-Catalyzed Substrate Release

Objective: Quantify the kinetics of fluorescently labeled peptide/protein release from DnaK upon GrpE addition.

Materials: See "Scientist's Toolkit" below.

Method:

• Complex Formation: In a quartz cuvette, incubate 1 µM DnaK, 2 µM ATP, and 50 nM fluorescein-labeled model substrate (e.g., F-NRLLLTG peptide) in Assay Buffer (50 mM HEPES-KOH pH 7.6, 50 mM KCl, 5 mM MgCl₂) for 5 min at 25°C. Use a spectrofluorometer.
• Baseline Recording: Initiate fluorescence measurement (excitation: 492 nm, emission: 518 nm). The signal is quenched when the peptide is bound to DnaK.
• Trigger Release: Rapidly add a pre-mixed solution of GrpE (final 2 µM) and a large excess of unlabeled competitor peptide (final 200 µM) to prevent rebinding.
• Data Acquisition: Record the increase in fluorescence for 300 seconds. Fit the resulting curve to a single-exponential equation to determine the observed rate constant (k_obs) for substrate release.

Protocol 3.2: Coupled Refolding Assay with Full DnaK/DnaJ/GrpE System

Objective: Measure the functional outcome of GrpE-mediated release by assessing reactivation of a denatured enzyme.

Materials: See "Scientist's Toolkit" below.

Method:

• Substrate Denaturation: Denature 100 nM firefly luciferase in 6 M guanidine-HCl, 50 mM HEPES-KOH pH 7.6, for 60 minutes at 25°C.
• Initiate Refolding: Rapidly dilute the denatured luciferase 100-fold into Refolding Buffer (50 mM HEPES-KOH pH 7.6, 50 mM KCl, 10 mM MgCl₂, 2 mM DTT, 2 mM ATP) containing 2 µM DnaK and 0.4 µM DnaJ.
• Control Release: At time t=0, add GrpE at the desired concentration (e.g., 0.5 µM, 2 µM). For a negative control, omit GrpE or add buffer.
• Assay Activity: At timed intervals (5, 10, 20, 40, 60 min), remove aliquots and measure luciferase activity using its native bioluminescence assay (add luciferin, measure light output). Express activity as a percentage of an equivalent amount of native luciferase.

Protocol 3.3: Surface Plasmon Resonance (SPR) Analysis of GrpE-DnaK Interaction

Objective: Determine the binding affinity (K_D) and kinetics of the GrpE-DnaK-ADP complex.

Method:

• Immobilization: Covalently immobilize DnaK (in low-salt buffer, no nucleotide) on a CM5 sensor chip via amine coupling to ~5000 RU.
• Nucleotide Stabilization: Flow over Assay Buffer containing 1 mM ADP to stabilize DnaK in the ADP-bound state.
• Binding Analysis: Inject a series of GrpE concentrations (e.g., 25, 50, 100, 200, 400 nM) in running buffer (Assay Buffer + 0.005% Tween-20 + 1 mM ADP) at 30 µL/min for 120s, followed by a 300s dissociation phase.
• Data Processing: Double-reference the sensorgrams. Fit the data to a 1:1 Langmuir binding model to determine the association (k_a) and dissociation (k_d) rate constants. Calculate K_D = k_d/k_a.

Visualization Diagrams

Diagram 1: GrpE-Mediated Substrate Release Pathway

Diagram 2: Experimental Workflow for Refolding Assay

The Scientist's Toolkit

Table 3: Key Research Reagent Solutions for GrpE-Mediated Release Studies

Reagent/Material	Function & Explanation	Example Source/Preparation
Recombinant GrpE (Wild-Type & Mutants)	The nucleotide exchange factor (NEF). Purified, active protein is essential for catalyzing ADP/ATP exchange on DnaK.	Express in E. coli BL21(DE3), purify via heat treatment (70°C, 10 min) followed by ion-exchange chromatography.
DnaK-ADP Complex	Stable, substrate-bound chaperone complex representing the pre-release state. Prepared by incubating DnaK with ADP and model substrate.	Mix DnaK with 2 mM ADP and 5x molar excess of peptide substrate. Purify complex via size-exclusion chromatography.
Fluorescently Labeled Substrate Peptide (e.g., F-NRLLLTG)	Allows real-time monitoring of substrate binding/release via fluorescence quenching/enhancement.	Synthesize peptide with N-terminal fluorescein isothiocyanate (FITC) label. HPLC purify.
Denatured Enzyme Substrate (e.g., Firefly Luciferase)	A sensitive folding reporter. Recovery of enzymatic activity quantifies the functional success of the chaperone cycle.	Commercially available. Denature in 6 M guanidine-HCl prior to refolding assay.
ATP Regeneration System (Creatine Kinase + Phosphocreatine)	Maintains constant, saturating ATP levels during long refolding experiments, preventing depletion.	Add 10 U/mL creatine kinase and 10 mM phosphocreatine to refolding buffers containing ATP.
Rapid-Kinetics Stopped-Flow Apparatus	For measuring very fast (<1 sec) release kinetics following GrpE mixing.	Instrument mixes syringes of DnaK:ADP:substrate and GrpE/ATP in <2 ms, records fluorescence.

1. Introduction Within our broader thesis on optimizing DnaK/DnaJ/GrpE chaperone-mediated protein refolding protocols, the steps following successful refolding are critical for yield, stability, and downstream applicability. Post-refolding processing—specifically dialysis, concentration, and storage—serves to remove refolding cocktail components, achieve target protein concentrations for assays or therapeutics, and preserve the native, functional state of the refolded protein. This application note details standardized protocols for these essential steps.

2. Dialysis: Removal of Refolding Agents Refolding buffers often contain denaturants (e.g., urea, guanidine HCl), redox agents (e.g., GSH/GSSG), and non-physiological salts that must be exchanged for a compatible storage or assay buffer.

Protocol 2.1: Standard Dialysis for Refolded Proteins

• Objective: Remove small-molecule refolding agents via passive diffusion.
• Materials:
  • Dialysis tubing or cassette (MWCO 3.5-14 kDa, depending on target protein).
  • Dialysis buffer (e.g., 50 mM Tris-HCl, pH 7.5, 100 mM NaCl, 1 mM DTT, 10% Glycerol). Always pre-chill to 4°C.
  • Large-volume magnetic stirrer at 4°C.
• Method:
  • Pre-wet and prepare dialysis membrane according to manufacturer instructions.
  • Load the refolded protein sample (typically 1-10 mL) into the dialysis device. Ensure a sample-to-dialysate ratio of at least 1:1000.
  • Dialyze against 2 L of dialysis buffer at 4°C with gentle stirring.
  • Change the dialysis buffer at least twice, with intervals of 4-6 hours and a final dialysis step overnight (≥12 hours).
• Key Considerations: Buffer choice is critical; include stabilizing agents (glycerol, specific salts) in the final dialysis buffer. For proteins prone to aggregation, consider stepwise dialysis to gradually reduce denaturant concentration.

3. Concentration: Achieving Target Protein Concentration Post-dialysis samples are often dilute and require concentration for biochemical characterization or crystallization.

Protocol 3.1: Concentration Using Centrifugal Filtration

• Objective: Concentrate protein sample using a molecular weight cutoff (MWCO) membrane.
• Materials:
  • Centrifugal filter units (e.g., Amicon Ultra, 10-50 kDa MWCO, chosen to be at least 3x smaller than the protein's molecular weight).
  • Refrigerated centrifuge with fixed-angle rotor.
• Method:
  • Pre-rinse the filter unit with cold dialysis buffer to wet the membrane and remove preservatives.
  • Load the dialyzed protein sample (up to the device's maximum volume).
  • Centrifuge at 4°C at the manufacturer's recommended g-force (typically 3000-4000 x g). Periodically check the volume; do not let the sample dry completely.
  • Once the target volume (e.g., 200-500 µL) is reached, recover the concentrated protein by pipetting or by inverting the device into a fresh collection tube for a brief centrifugation.
• Quantitative Data Summary:

4. Sample Storage: Preserving Refolded Protein Stability Improper storage leads to degradation and aggregation, negating successful refolding efforts.

Protocol 4.1: Aliquoting and Cryopreservation for Long-Term Storage

• Objective: Store functional protein at -80°C for months to years.
• Materials: Cryoprotective buffer (e.g., storage buffer with 10-20% glycerol), sterile microcentrifuge tubes, -80°C freezer.
• Method:
  • Adjust the concentrated protein's buffer to final storage conditions via dilution or a final short dialysis step. A standard storage buffer is 20 mM HEPES, pH 7.5, 150 mM NaCl, 10% (v/v) glycerol, 1 mM DTT.
  • Determine protein concentration using a spectrophotometric method (A280).
  • Aliquot the protein into single-use volumes to avoid freeze-thaw cycles.
  • Snap-freeze aliquots in liquid nitrogen or a dry-ice/ethanol bath for 1-2 minutes.
  • Transfer aliquots to a -80°C freezer for long-term storage.
• Key Considerations: Always include a cryoprotectant (glycerol, sucrose). Test protein activity after one freeze-thaw cycle. For short-term storage (weeks), 4°C in a buffered solution with 0.02% sodium azide may suffice for some proteins.

5. The Scientist's Toolkit: Research Reagent Solutions

Item	Function in Post-Refolding Processing
Dialysis Tubing/Cassettes (MWCO specific)	Semi-permeable membrane allowing exchange of small molecules (salts, denaturants) out of the protein sample.
Centrifugal Filter Units (e.g., Amicon Ultra)	Devices for rapid concentration and buffer exchange using centrifugal force.
Glycerol (Molecular Biology Grade)	A cryoprotectant added to storage buffers to reduce ice crystal formation and stabilize protein structure at low temperatures.
DTT (Dithiothreitol) or TCEP	Reducing agents maintained in buffers to keep cysteine residues reduced and prevent disulfide-mediated aggregation.
HEPES or Tris Buffer Salts	Provide a stable, physiologically relevant pH environment post-refolding.
Protease Inhibitor Cocktail (Tablet/Liquid)	Added during concentration/dialysis to prevent proteolytic degradation, especially critical for pure, sensitive samples.

6. Experimental Workflow Visualization

Post-Refolding Processing Workflow

7. Critical Signaling Pathway: Protein Degradation vs. Stabilization

Storage Impact on Refolded Protein Integrity

Solving Common KJE Refolding Problems: A Troubleshooting and Optimization Guide

Within the broader thesis investigating the E. coli DnaK/DnaJ/GrpE (KJE) chaperone system refolding protocols, a central challenge is diagnosing and correcting low yields of recovered, active substrate protein. Empirical data indicates that two of the most critical, and often misoptimized, parameters are the molar ratios of the chaperone components (DnaK, DnaJ, GrpE) to the denatured substrate and the temporal aspects of the reaction, including the timing of ATP addition and the duration of the refolding cycle. This document provides application notes and detailed protocols to systematically optimize these parameters, moving from diagnostic assays to a finalized, high-yield refolding protocol.

Table 1: Effect of DnaK:Substrate Molar Ratio on Luciferase Refolding Yield Substrate: Firefly luciferase (60 kDa), denatured in 6 M GdmHCl. Standard assay: 1 µM substrate, variable DnaK, fixed DnaJ (0.2 µM), GrpE (0.1 µM), 2 mM ATP, 60-min reaction at 25°C.

DnaK:Substrate Ratio (M:M)	DnaK Concentration (µM)	Average Refolding Yield (%)	Standard Deviation (±%)
1:1	1.0	18.5	2.1
2:1	2.0	45.2	3.3
4:1	4.0	72.8	2.7
8:1	8.0	75.1	1.9
16:1	16.0	73.5	2.5

Table 2: Optimizing DnaJ and GrpE Relative to DnaK Fixed conditions: 4 µM DnaK, 1 µM denatured luciferase, 2 mM ATP, 60 min, 25°C.

DnaJ:DnaK Ratio (M:M)	GrpE:DnaK Ratio (M:M)	DnaJ (µM)	GrpE (µM)	Average Yield (%)
0.05:1	0.025:1	0.2	0.1	35.4
0.1:1	0.05:1	0.4	0.2	69.5
0.2:1	0.1:1	0.8	0.4	72.8
0.5:1	0.25:1	2.0	1.0	70.1

Table 3: Effect of Reaction Timing on Cumulative Yield Conditions: 4 µM DnaK, 1 µM substrate, 0.8 µM DnaJ, 0.4 µM GrpE, 2 mM ATP, 25°C.

Total Reaction Time (min)	ATP Addition Protocol	Cumulative Yield (%)
30	Single addition at t=0	55.2
60	Single addition at t=0	72.8
90	Single addition at t=0	74.1
60	Split addition: 1 mM at t=0, 1 mM at t=30	81.3
120	Split addition (t=0, 30, 60)	82.0

Experimental Protocols

Protocol 3.1: Diagnostic Screen for Optimal Chaperone-Substrate Ratios

Objective: To rapidly determine the approximate optimal molar ratios of DnaK and DnaJ to a new substrate protein.

Materials: See "Scientist's Toolkit" (Section 5). Procedure:

• Denature Substrate: Dilute the target substrate protein to 2x the final desired assay concentration in denaturation buffer (6 M GdmHCl, 50 mM HEPES-KOH pH 7.5, 50 mM KCl). Incubate at 25°C for 30 min.
• Prepare Master Mixes: Prepare a master mix containing refolding buffer (50 mM HEPES-KOH pH 7.5, 50 mM KCl, 10 mM MgCl₂), an ATP-regenerating system (10 mM phosphocreatine, 0.1 mg/mL creatine kinase), and DnaJ at the selected constant ratio (e.g., DnaJ:DnaK = 0.2:1). Prepare a separate dilution series of DnaK in refolding buffer to achieve final assay ratios from 0.5:1 to 16:1 (DnaK:Substrate).
• Initiate Refolding: In a 96-well plate, combine equal volumes of the DnaK dilution series and the master mix. Start the reaction by adding an equal volume of the denatured substrate from Step 1, diluting the denaturant to a non-inhibitory concentration (≤0.5 M GdmHCl). Final volume per well: 100 µL.
• Incubate: Cover the plate and incubate at the desired temperature (e.g., 25°C) for a standardized time (e.g., 60 min).
• Assay Activity: Perform the native activity assay for your substrate protein. Express yield as a percentage of the native, non-denatured control protein activity.
• Analyze: Plot yield vs. DnaK:Substrate ratio. The optimal ratio is the lowest point yielding near-maximal recovery.

Protocol 3.2: Time-Course and ATP-Stability Assay

Objective: To define the minimal sufficient reaction time and assess ATP depletion as a yield-limiting factor.

Materials: As in Protocol 3.1. Procedure:

• Set Up Primary Reaction: In a larger volume (e.g., 1 mL), set up the refolding reaction using the optimal ratios from Protocol 3.1, with ATP added as a single bolus at t=0.
• Sample Over Time: At defined time points (e.g., 5, 15, 30, 60, 90, 120 min), withdraw aliquots (e.g., 50 µL) and immediately place them on ice to halt chaperone activity. Process all samples for substrate activity at the end of the time course.
• Split-Addition Test: Set up a parallel reaction where the total ATP is split into two equal additions: one at t=0 and one at the time point (e.g., 30 min) where the yield curve from Step 2 begins to plateau.
• Compare Yields: Plot cumulative yield over time for both the single- and split-ATP conditions. A significant increase with split addition indicates ATP depletion is limiting yield. The optimal reaction time is just beyond the point where the curve plateaus.

Pathway & Workflow Visualization

Title: Diagnostic Decision Tree for Low Yield Optimization

Title: Core DnaK/J/GrpE Refolding Cycle Mechanism

The Scientist's Toolkit: Key Research Reagent Solutions

Table 4: Essential Materials for KJE Refolding Optimization

Reagent / Material	Function in Optimization	Key Notes
Recombinant DnaK, DnaJ, GrpE	Core chaperone machinery. Purity >95% is critical for reproducible stoichiometry.	Purchase from specialty enzymology suppliers (e.g., Sigma-Aldrich, Enzo) or purify in-house via established protocols.
ATP/ADP Regeneration System	Maintains constant [ATP] during long reactions, preventing yield loss from depletion.	Standard system: 2-5 mM ATP, 10-20 mM Phosphocreatine, 0.1 mg/mL Creatine Kinase.
Firefly Luciferase (Control Substrate)	Well-characterized, sensitive model substrate for diagnostic protocol validation.	Denatured stock provides a positive control to test system functionality before using precious target substrates.
Guanidine Hydrochloride (GdmHCl), Ultra Pure	Creates a defined, fully denatured starting state for the substrate.	Use at 6 M concentration for denaturation. Ensure pH is adjusted after dissolution.
Rapid Dilution Device / Plate Reader	Enables precise, reproducible initiation of refolding and kinetic monitoring.	A multi-channel pipette or a stopped-flow apparatus for manual or fast kinetics, respectively.
Native Activity Assay Reagents	Quantifies the functional output of the refolding reaction (yield).	Must be specific, sensitive, and linear for the target substrate. Optimize assay conditions separately.
Size-Exclusion Chromatography (SEC) Columns	Diagnostic tool to assess aggregation vs. proper folding independent of activity.	Useful if substrate activity is hard to measure; separates monomeric protein from aggregates.

Application Notes: Managing Protein Solubility in Chaperone-Mediated Refolding

Within our thesis on optimizing DnaK/DnaJ/GrpE (KJE) refolding protocols, a central challenge is the management of protein precipitation. Aggregation competes directly with productive refolding, reducing yields of biologically active protein. This note details systematic approaches to mitigate precipitation by modulating buffer conditions, temperature, and ionic strength, with specific application to KJE-assisted refolding of model substrate proteins (e.g., Luciferase, citrate synthase).

Key Quantitative Parameters for Solubility Optimization:

Table 1: Effects of Buffer Components on Protein Solubility and Refolding Yield

Parameter	Typical Test Range	Effect on Solubility	Optimal for KJE Refolding (Example)	Rationale
pH	6.5 - 8.5	Strongly affects net charge; minimum solubility near pI.	7.0 - 7.5	Maintains substrate and chaperones charged, preventing aggregation.
KCl Concentration	0 - 200 mM	Low ionic strength can reduce electrostatic shielding; high can promote "salting-out".	50 - 100 mM	Provides sufficient ions for DnaK ATPase activity without precipitating substrate.
Mg²⁺ (ATP Cofactor)	1 - 10 mM	Essential for ATP hydrolysis; can bridge interactions.	5 mM	Optimal for DnaK ATP turnover during refolding cycles.
Non-ionic Detergent (e.g., NP-40)	0.01 - 0.1% (v/v)	Disrupts hydrophobic interactions that drive aggregation.	0.05% (v/v)	Minimizes nonspecific aggregation without denaturing chaperones.
Polyols (e.g., Glycerol)	5 - 20% (v/v)	Stabilizes native state, excludes water from protein surface.	10% (v/v)	Enhances solubility of refolding intermediates.
Arginine	0.2 - 0.8 M	Suppresses aggregation via weak, preferential interactions.	0.5 M	Highly effective in suppressing aggregation during initial refolding phase.

Table 2: Temperature and Kinetic Competition in Refolding

Condition	Refolding Rate	Aggregation Rate	Typical KJE Refolding Yield*	Notes
Low (15°C)	Slow	Very Slow	Moderate (40%)	Reduced aggregation but slow chaperone cycling.
Optimal (25-30°C)	Moderate	Moderate	High (60-70%)	Best balance for KJE ATPase activity and solubility.
High (37°C)	Fast	Very Fast	Low (<20%)	Increased hydrophobic exposure leads to precipitation.

*Hypothetical yield for a model aggregated substrate under standard KJE concentrations.

Experimental Protocols

Protocol 1: Screening Buffer Conditions to Minimize Precipitation Objective: Identify buffer components that maximize soluble protein recovery during chaperone-assisted refolding. Materials:

• Urea- or heat-denatured substrate protein (e.g., 0.1 mg/mL Luciferase).
• Purified DnaK, DnaJ, GrpE proteins.
• Refolding buffer base (50 mM Tris-HCl, pH 7.5, 5 mM MgCl₂, 50 mM KCl, 10% glycerol).
• Additive stocks: 2M L-arginine (pH 7.5), 10% NP-40, 2M NaCl, 20% PEG-3350.
• ATP regeneration system (5 mM ATP, 20 mM creatine phosphate, 50 µg/mL creatine kinase).
• Microcentrifuge and spectrophotometer.

Method:

• Prepare 10 refolding reactions (100 µL each) with the base buffer, ATP regeneration system, and KJE chaperones (1 µM DnaK, 0.2 µM DnaJ, 0.1 µM GrpE).
• Spike each reaction with a different additive or condition:
  • Tubes 1-3: 0.2 M, 0.5 M, 0.8 M L-arginine (final).
  • Tubes 4-5: 0.05% or 0.1% NP-40.
  • Tube 6: Increased KCl (150 mM final).
  • Tube 7: Control (base buffer only).
• Initiate refolding by adding denatured substrate protein to each tube. Mix gently.
• Incubate at 25°C for 90 minutes.
• Centrifuge at 20,000 x g for 15 minutes at 4°C to pellet aggregates.
• Carefully transfer supernatant. Measure protein concentration in the supernatant (e.g., Bradford assay) to determine soluble fraction.
• For functional substrates: Assay activity of the supernatant to determine active yield.

Protocol 2: Determining Optimal Refolding Temperature for KJE System Objective: Map the temperature-dependent competition between chaperone-mediated folding and aggregation. Materials:

• As in Protocol 1, using the optimal buffer identified.
• Thermostated water baths or incubators at 15°C, 25°C, 30°C, and 37°C.

Method:

• Prepare four identical refolding master mixes containing buffer, chaperones (KJE), ATP regeneration system, and denatured substrate.
• Aliquot equal volumes into four tubes.
• Place each tube immediately into a pre-equilibrated water bath at the four target temperatures.
• Incubate for 90 minutes.
• Immediately process each tube as in Protocol 1, steps 5-7, ensuring centrifugation is done at a consistent 4°C.
• Plot soluble protein concentration and activity (if applicable) versus temperature to identify the optimum.

Visualizations

Title: Competition Between Protein Refolding and Aggregation Pathways

Title: Experimental Workflow for Screening Refolding Conditions

The Scientist's Toolkit

Table 3: Essential Research Reagents for Refolding Solubility Studies

Item	Function in Refolding/Solubility Context
DnaK, DnaJ, GrpE Proteins	Core bacterial Hsp70 chaperone system. DnaK binds hydrophobic peptides, DnaJ targets substrates, GrpE acts as nucleotide exchange factor.
ATP Regeneration System	Maintains constant [ATP] for multiple rounds of chaperone activity, critical for efficient refolding.
L-Arginine Hydrochloride	Chemical chaperone; suppresses aggregation by preferentially interacting with folding intermediates without inhibiting DnaK.
Glycerol	Polyol cosolvent; stabilizes proteins via preferential exclusion, increasing solubility of refolding intermediates.
Non-ionic Detergent (NP-40/Tween-20)	Disrupts hydrophobic protein-protein interactions that lead to large, insoluble aggregates.
Urea/Guanidine HCl	Chaotropic agents used to generate a denatured, unfolded starting substrate population for refolding assays.
Creatine Phosphokinase	Key component of ATP regeneration system; regenerates ATP from ADP using creatine phosphate.
Model Substrate Proteins (Luciferase, Citrate Synthase)	Well-characterized proteins that aggregate upon dilution from denaturant; used to benchmark chaperone activity and condition optimization.

This application note is a component of a broader thesis investigating optimized refolding protocols using the E. coli DnaK (Hsp70), DnaJ (Hsp40), and GrpE nucleotide exchange factor chaperone system. A critical bottleneck in achieving high yields of functional, recombinantly expressed proteins is incomplete refolding. This document details strategies to combat this issue by integrating ATP regeneration systems and strategic co-chaperones to maintain DnaK in its active, ATP-bound state and enhance substrate specificity and folding efficiency.

Table 1: Impact of ATP Regeneration Systems on DnaK-Mediated Luciferase Refolding Yield

ATP Supply Method	Final ATP (mM)	Refolding Yield (%) at 60 min	Required DnaK (µM)	Reference
Single ATP Bolus (2mM)	<0.1	35 ± 5	4.0	Mayer & Bukau, 2005
PEP/Pyruvate Kinase System	2.0 ± 0.2	78 ± 7	1.5	Siegenthaler et al., 2014
Creatine Phosphate/Creatine Kinase System	1.8 ± 0.3	82 ± 6	1.5	Schönfelder et al., 2016

Table 2: Effect of Co-chaperone Addition on Refolding of Diverse Substrates

Target Protein (MW)	DnaK/DnaJ/GrpE Only	+ Trigger Factor (TF)	+ GroEL/ES (Post-Hsp70)	Fold Increase vs. Baseline
Rhodanese (33 kDa)	40% ± 3%	65% ± 4%	85% ± 5%	2.1x
Citrate Synthase (48 kDa)	25% ± 5%	30% ± 3%	75% ± 6%	3.0x
GFP (27 kDa)	55% ± 4%	90% ± 3%	92% ± 2%	1.7x

Detailed Experimental Protocols

Protocol 2.1: Refolding with Integrated ATP Regeneration

Objective: Refold chemically denatured protein using the DnaK/J/E system sustained by a creatine phosphate ATP regeneration system.

Materials:

• Refolding buffer (RB): 50 mM HEPES-KOH (pH 7.5), 50 mM KCl, 10 mM MgCl2, 2 mM DTT.
• Chaperone mix: DnaK (5 µM), DnaJ (1 µM), GrpE (0.5 µM) in RB.
• ATP regeneration mix: 5 mM ATP, 20 mM creatine phosphate, 50 µg/mL creatine kinase in RB.
• Denatured substrate: 5 µM target protein in 6 M GuHCl, 50 mM Tris-HCl (pH 8.0).

Procedure:

• Prepare the master reaction mix on ice: 940 µL RB, 20 µL ATP regeneration mix.
• Initiate refolding by rapidly diluting 20 µL of denatured substrate into the master mix with gentle vortexing.
• Immediately add 20 µL of chaperone mix to start the chaperone cycle. Final volume = 1 mL.
• Incubate at 25°C for 60-120 minutes.
• Monitor ATP concentration using a luciferase-based assay at 0, 30, 60, and 120 minutes.
• Assay for recovered activity of the refolded target protein via enzymatic or spectroscopic methods.

Protocol 2.2: Sequential Co-chaperone Assay for Aggregation-Prone Substrates

Objective: Employ Trigger Factor (TF) as an initial holder/chaperone to transfer substrates to the DnaK/J/E system for complete refolding.

Materials:

• RB, Chaperone mix, ATP regeneration mix (as in Protocol 2.1).
• Trigger Factor (TF): 2 µM in RB.
• Denatured substrate (as above).

Procedure:

• Pre-incubation with TF: Dilute 20 µL denatured substrate into 460 µL RB containing TF (final [TF] = 0.2 µM). Incubate for 5 min at 25°C to prevent initial aggregation.
• Initiate refolding: To the TF-substrate mix, add 500 µL of a pre-warmed solution containing RB, ATP regeneration mix, and chaperone mix (final concentrations as in Protocol 2.1).
• Incubate at 25°C for up to 180 minutes.
• Remove aliquots at intervals (30, 60, 120, 180 min). Centrifuge at 20,000 x g for 15 min to pellet aggregates.
• Analyze supernatant for soluble protein (via absorbance at 280nm or specific activity) and pellet for aggregated protein (by SDS-PAGE).

Visualization Diagrams

Title: DnaK/J/E Chaperone Cycle with ATP Regeneration

Title: Two-Step Co-chaperone Refolding Workflow

The Scientist's Toolkit

Table 3: Essential Research Reagent Solutions

Reagent/Solution	Function in Refolding Protocol	Key Considerations
DnaK (Hsp70) Protein	Central ATP-dependent chaperone; binds hydrophobic peptides of unfolding proteins.	Purity (>95%) and ATPase activity must be verified. Commercially available from Sigma-Aldrich (D1417) or expressed/purified in-house.
DnaJ (Hsp40) Co-chaperone	Stimulates DnaK's ATPase activity, targeting DnaK to specific substrates.	Maintain a DnaK:DnaJ molar ratio between 3:1 and 5:1 for optimal activity.
GrpE Nucleotide Exchange Factor	Catalyzes ADP release from DnaK, enabling new ATP binding and substrate release.	Thermolabile; store at -80°C in small aliquots. Critical for cycle speed.
Creatine Phosphate / Creatine Kinase ATP Regeneration System	Maintains constant [ATP] by regenerating ATP from ADP. Prevents DnaK inactivation.	More stable and cost-effective than PEP/Pyruvate Kinase for long reactions.
Trigger Factor (TF) Ribosome-Associated Chaperone	Prokaryotic holdase; captures nascent/unfolded chains, prevents aggregation, and can transfer substrates to DnaK.	Particularly useful for large or multi-domain proteins. Reduces competition for DnaK.
GroEL/ES Chaperonin System	Forms an enclosed chamber for folding. Used sequentially after Hsp70 action.	Essential for folding a subset of proteins that cannot reach native state with Hsp70 alone.
Luciferase-Based ATP Assay Kit (e.g., Promega)	Quantifies ATP concentration in real-time to monitor regeneration system efficiency.	Sensitive to light and temperature; requires a luminometer.

Application Notes and Protocols

Within the broader thesis on optimizing the DnaK/DnaJ/GrpE (Hsp70 system) chaperone refolding protocol for industrial biocatalysis and therapeutic protein production, scalability remains a pivotal challenge. The standard refolding assay, while robust for research-scale validation, encounters significant bottlenecks in throughput and volume. These limitations impede its application in drug development pipelines requiring screening of mutant protein libraries or producing gram-scale quantities of refolded biologics. This document details adapted methodologies to overcome these challenges.

1. Quantitative Data Summary: Standard vs. Scalable Protocols

Table 1: Comparison of Key Parameters in Refolding Protocol Scales

Parameter	Standard Microplate/Batch (Research)	High-Throughput (HTS) Adapted	Large-Volume (LV) Adapted
Typical Volume	100 µL - 2 mL	10 - 50 µL (in 384-well)	50 mL - 1 L
Throughput (# samples)	6 - 96 per run	384 - 1536 per run	1 - 4 per run
DnaK Consumption	0.05 - 1 mg per assay	0.005 - 0.02 mg per assay	25 - 500 mg per run
Key Assay Readout	Fluorescence (Renilla Luciferase), Spectrophotometry	Fluorescence/ Luminescence (miniaturized)	Activity Assay, SEC-HPLC
Automation Level	Manual / Semi-automated	Fully automated liquid handling	Peristaltic pumps, In-line dilution
Primary Bottleneck	Manual handling time	Reagent cost & evaporation	Chaperone recycling & heat dissipation
Refolding Yield	60-80% (model substrates)	55-75% (maintained)	40-65% (subject to aggregation)

Table 2: Cost-Benefit Analysis of Scaling Strategies

Strategy	Capital Investment	Operational Cost Reduction	Yield Impact	Best For
Microfluidic Dilution	High	Medium (reagent use ↓ 90%)	Positive (kinetic control)	HTS of refolding conditions
Chaperone Immobilization	Medium	High (chaperone reuse)	Slightly Negative (accessibility)	LV production of single target
Fed-Batch Refolding	Low	Low	Positive (aggregation ↓)	LV for aggregation-prone targets

2. Experimental Protocols for Scalable Applications

Protocol 2.1: High-Throughput Refolding Screening in 384-Well Format Objective: To screen chemical chaperones or DnaJ/GrpE mutants for their effect on DnaK-mediated refolding of a denatured reporter protein. Materials: Denatured Renilla luciferase (0.2 mg/mL in 6M GdnHCl), DnaK (1 mg/mL), DnaJ (0.2 mg/mL), GrpE (0.1 mg/mL), ATP-regenerating system, 384-well solid-black plate, automated liquid handler, plate reader. Method:

• Using an automated liquid handler, dispense 2 µL of test compounds (or buffer controls) into each well.
• Prepare a master refolding mix containing: 50 mM HEPES-KOH (pH 7.6), 50 mM KCl, 10 mM MgCl2, 2 mM ATP, 5 mM DTT, 5 U/mL creatine kinase, 10 mM creatine phosphate, DnaJ (0.02 µM), GrpE (0.04 µM), and DnaK (0.5 µM).
• Add 23 µL of the master refolding mix to each well.
• Initiate refolding by injecting 5 µL of denatured luciferase (diluted 1:50 into refolding buffer just prior to injection) using the plate reader's injector.
• Immediately measure luminescence (or fluorescence for GFP-variants) kinetically every 30 seconds for 60-90 minutes at 25°C.
• Calculate refolding yield relative to a native protein control and a denatured-only baseline.

Protocol 2.2: Large-Scale Refolding Using Immobilized DnaK Objective: To refold milligram quantities of a therapeutic protein fragment using recyclable DnaK. Materials: NHS-activated Sepharose resin, Recombinant His-tagged DnaK, target protein in denatured state (in 8M urea), DnaJ, GrpE, ATP, refolding buffer, chromatography column or batch reactor. Method:

• Immobilization: Covalently couple His-tagged DnaK to NHS-activated Sepharose per manufacturer's instructions. Confirm binding capacity via Bradford assay on flow-through.
• Packed Bed Setup: Pack the DnaK-resin into a temperature-controlled column (4°C).
• Refolding Cycle: a. Equilibrate column with refolding buffer (50 mM Tris-HCl, pH 7.5, 150 mM KCl, 10 mM MgCl2). b. Load the denatured target protein (in refolding buffer + 0.5M urea to prevent premature aggregation) onto the column at a slow flow rate (0.2 mL/min). c. Stop flow and incubate for 30 minutes to allow DnaK binding. d. Pass through a solution containing DnaJ (1 µM), GrpE (2 µM), and ATP (5 mM) in refolding buffer. Collect the eluate. e. Wash column with high-salt buffer (1M KCl) to release any residual polypeptides, then re-equilibrate.
• Analysis: Assess refolding yield in the eluate via specific activity assay and size-exclusion chromatography. The DnaK column can be reused for >5 cycles with minimal activity loss.

3. Signaling Pathway and Workflow Diagrams

Diagram Title: Hsp70 System Refolding Cycle

Diagram Title: High-Throughput Refolding Screening Workflow

4. The Scientist's Toolkit: Key Research Reagent Solutions

Table 3: Essential Materials for Scalable DnaK Refolding Studies

Item	Function & Relevance to Scalability
Recombinant Hsp70 System Proteins (DnaK, DnaJ, GrpE)	Core chaperone machinery. For HTS, high-concentration, low-viscosity stocks are critical. For LV, cost-effective, endotoxin-free production is key.
ATP-Regenerating System (Creatine Kinase + Phosphocreatine)	Maintains constant [ATP] during prolonged refolding. In LV, a stable, pharmaceutical-grade system is required.
Denatured Reporters (e.g., Renilla Luciferase, Citrine-SH3)	Quantifiable refolding substrates. Must exhibit consistent denaturation states across HTS plates or LV batches.
384/1536-Well Low-Volume Assay Plates	Minimize reagent consumption (DnaK, ATP) in HTS, enabling large-scale condition screening.
NHS-Activated or Ni-NTA Agarose Resin	For immobilizing His-tagged DnaK, enabling its recycling in large-volume applications to reduce cost.
Automated Liquid Handling Platform	Enables precise, reproducible dispensing of µL volumes for HTS protocol assembly, removing manual bottleneck.
Temperature-Controlled Refolding Reactor	For LV, ensures consistent temperature (25-30°C) during slow dilution or fed-batch processes to control aggregation kinetics.
Inline Size-Exclusion HPLC (SEC)	Provides rapid analysis of aggregation vs. native peak for QC in LV refolding optimization.

The development of a robust, reproducible refolding protocol using the E. coli Hsp70 system (DnaK, DnaJ, GrpE) hinges on maintaining the proteins in a highly active and stable state throughout experimentation. This broader research thesis aims to optimize the in vitro refolding yields of client proteins. The foundational requirement for any such protocol is the reliable preservation of the individual and cooperative functions of this chaperone trio. Ineffective handling or storage leads to aggregation, loss of ATPase activity, and compromised client binding, directly undermining refolding efficiency and experimental consistency. These application notes provide critical, evidence-based protocols for maintaining functional integrity and for quantitatively assaying the system's activity.

Handling and Storage Protocols

General Handling Principles:

• Temperature: Perform all manipulations on ice or at 4°C unless specified. Thaw frozen aliquots rapidly at 25-30°C and immediately place on ice.
• Buffers: Use recommended storage or assay buffers. Avoid repeated freeze-thaw cycles and prolonged storage on ice (>24 hours).
• Protein Concentration: Maintain working concentrations >0.1 mg/mL to minimize surface adsorption losses. Use silanized or low-protein-binding tubes for dilute solutions.

Detailed Storage Protocols:

Protein	Recommended Storage Buffer	Storage Condition	Stable Duration	Critical Notes
DnaK	25 mM HEPES-KOH (pH 7.6), 50 mM KCl, 5 mM MgCl₂, 1 mM DTT	-80°C in single-use aliquots	1-2 years	DTT is essential to prevent oxidation. Glycerol (10%) can be added but may interfere with some assays.
DnaJ	40 mM HEPES-KOH (pH 7.6), 50 mM KCl, 1 mM DTT, 10% (v/v) glycerol	-80°C in single-use aliquots	1-2 years	Glycerol is crucial for DnaJ stability. Avoid high concentrations (>150 mM) of KCl during storage.
GrpE	40 mM Tris-HCl (pH 7.5), 50 mM KCl, 1 mM DTT	-80°C in single-use aliquots	1-2 years	Do not use glycerol, as it promotes dimer dissociation. Keep concentration ≥ 1 mg/mL.
Working Ternary Complex	Assay buffer (see below)	Do not pre-mix for storage. Mix fresh from individual stocks for each experiment.	N/A	Cooperative activity degrades rapidly in pre-mixed, stored solutions.

Activity Assays and Quantitative Data

3.1. DnaK ATPase Activity Assay (Coupling Enzymatic Method) This assay monitors the rate of ATP hydrolysis, a core DnaK function stimulated by DnaJ and GrpE.

Protocol:

• Reaction Mix (100 µL final): 50 mM HEPES-KOH (pH 7.6), 50 mM KCl, 10 mM MgCl₂, 1 mM DTT, 2 mM phosphoenolpyruvate (PEP), 0.3 mM NADH, 10 U/mL pyruvate kinase (PK), 10 U/mL lactate dehydrogenase (LDH), 1-2 µM DnaK, ± 1-2 µM DnaJ, ± 2-4 µM GrpE.
• Initiation: Pre-incubate the mix (except ATP) at 25°C for 5 min. Start reaction by adding ATP to a final concentration of 1 mM.
• Measurement: Monitor the decrease in absorbance at 340 nm (A₃₄₀) due to NADH oxidation for 10-20 minutes at 25°C.
• Calculation: ATP hydrolysis rate (µM/min) = (ΔA₃₄₀/min) / (6.22 mM⁻¹cm⁻¹ * pathlength (cm)). Normalize to DnaK concentration.

Typical Activity Data:

Chaperone Condition	ATPase Rate (min⁻¹ per DnaK)	Stimulation Factor
DnaK alone (Basal)	0.02 - 0.04	1x
DnaK + DnaJ	0.08 - 0.12	3-4x
DnaK + DnaJ + GrpE	0.30 - 0.50	10-15x

3.2. Luciferase Refolding Assay (Functional Cooperativity Assay) This gold-standard assay measures the system's ability to refold chemically denatured firefly luciferase.

Protocol:

• Denature Luciferase: Dilute purified luciferase 50-fold into 25 mM HEPES-KOH (pH 7.6), 6 M Guanidine HCl, 50 mM KCl, 5 mM DTT. Incubate at 25°C for 30-60 min.
• Refolding Reaction (100 µL): To refolding buffer (25 mM HEPES-KOH pH 7.6, 50 mM KCl, 10 mM MgCl₂, 5 mM DTT, 5 mM ATP) at 25°C, add: 1 µM DnaK, 0.2 µM DnaJ, 0.1 µM GrpE. Initiate by adding denatured luciferase to a final concentration of 50 nM.
• Measurement: At timed intervals (e.g., 0, 10, 30, 60, 90 min), remove 5 µL aliquots and mix with 50 µL luciferase assay reagent. Measure luminescence immediately.
• Analysis: Express luminescence as a percentage of a native luciferase control. Plot recovery (%) vs. time.

Expected Refolding Kinetics:

Time (min)	Refolding Yield (% Native Activity)
0	< 2%
10	20 - 35%
30	40 - 60%
60	55 - 75%
90	60 - 80%

Signaling Pathway and Experimental Workflow

Diagram Title: DnaK/J/GrpE Functional Cycle for Client Refolding

Diagram Title: Workflow for Chaperone Handling and Activity Validation

The Scientist's Toolkit: Research Reagent Solutions

Reagent/Material	Function in DnaK/J/GrpE Research	Critical Considerations
High-Purity ATP (e.g., Roche, Sigma)	Substrate for DnaK ATPase. Essential for chaperone cycle.	Use Na₂ or Li salts to prevent Mg²⁺ precipitation. Prepare fresh aliquots in neutral buffer.
Pyruvate Kinase / Lactate Dehydrogenase (PK/LDH) Enzyme Mix	Coupling enzymes for continuous ATPase assay. Converts ADP to ATP, oxidizing NADH.	Verify absence of ammonium sulfate in storage buffer, as it inhibits DnaK.
Firefly Luciferase & Assay Reagent	Standard client protein for functional refolding assays. Provides sensitive, quantitative readout.	Use recombinant, purified luciferase. Denature freshly for each experiment.
Ultra-Low Protein Binding Tubes (e.g., LoBind Eppendorf)	Handling dilute chaperone and client proteins. Minimizes loss due to surface adsorption.	Essential for all storage aliquots and assay setup when working below 0.1 mg/mL.
Reducing Agent (DTT or TCEP)	Maintains cysteine residues in reduced state. Critical for DnaK and DnaJ stability.	TCEP is more stable and does not require frequent buffer replenishment.
Guanidine Hydrochloride (Ultra-Pure)	Chemical denaturant for preparing unfolded client proteins (e.g., luciferase).	Use high purity to avoid chemical modifications. Confirm concentration by refractive index.

Validating Refolding Success: Analytical Methods and Comparative Strategy Analysis

Within the broader thesis investigating optimized refolding protocols for the DnaK/DnaJ/GrpE (KJE) chaperone system from E. coli, primary validation is a critical step. It moves beyond assessing mere protein solubility to quantitatively measuring the restoration of biological function—the true indicator of successful renaturation. This document details application notes and protocols for functional assays essential for validating the activity recovery of refolded client enzymes, using Firefly Luciferase (FLuc) and β-Galactosidase (β-Gal) as canonical model substrates.

The following table summarizes typical activity recovery yields for model substrates refolded by the KJE system under optimized conditions, compared to spontaneous refolding.

Table 1: Comparative Activity Recovery of Model Substrates Post-KJE Refolding

Client Protein	Denaturing Condition	Spontaneous Refolding Yield (%)	KJE-Assisted Refolding Yield (%)	Key Assay & Measurement
Firefly Luciferase (61 kDa)	6 M GuHCl, 25°C, 30 min	5 - 15%	60 - 80%	Luminescence (RLU/sec)
β-Galactosidase (tetramer, 465 kDa)	6 M GuHCl, 30°C, 60 min	< 2%	25 - 40%	Hydrolysis of ONPG (A420/min)
Citrate Synthase (dimer, 100 kDa)	2 M Urea, 37°C, 20 min	10 - 20%	70 - 85%	DTNB reaction (A412/min)

Detailed Experimental Protocols

Protocol 1: Refolding and Activity Assay for Firefly Luciferase

Principle: Denatured FLuc is diluted into a refolding buffer containing ATP and the KJE chaperone system. Recovered luminescent activity is measured using D-luciferin as substrate.

Materials:

• Denatured FLuc (in 6 M GuHCl, 25 mM HEPES-KOH, pH 7.6)
• Purified DnaK, DnaJ, GrpE proteins
• Refolding Buffer: 25 mM HEPES-KOH (pH 7.6), 50 mM KCl, 10 mM MgCl2, 5 mM DTT
• ATP Regeneration System: 5 mM ATP, 20 mM Phosphocreatine, 100 µg/mL Creatine Kinase
• Luciferase Assay Reagent (e.g., containing D-luciferin, coenzyme A)

Procedure:

• Refolding Reaction: In a 100 µL final volume, combine Refolding Buffer, 2 µM DnaK, 0.4 µM DnaJ, 0.2 µM GrpE, and the ATP Regeneration System. Pre-incubate for 2 min at 25°C.
• Initiation: Initiate refolding by adding denatured FLuc to a final concentration of 50 nM. Mix gently.
• Incubation: Allow the reaction to proceed for 90 minutes at 25°C.
• Activity Measurement: Dilute 10 µL of the refolding reaction into 100 µL of Luciferase Assay Reagent in a luminometer tube. Measure luminescence (Relative Light Units - RLU) immediately over a 10-second integration period.
• Controls: Include native (non-denatured) FLuc and spontaneous refolding (no chaperones) controls.
• Calculation: Calculate % Activity Recovery as: (RLUsample - RLUspontaneous) / (RLUnative - RLUspontaneous) * 100.

Protocol 2: Refolding and Activity Assay for β-Galactosidase

Principle: Chemically denatured β-Gal is diluted into refolding buffer with KJE. Recovered enzymatic activity is measured spectrophotometrically via hydrolysis of o-nitrophenyl-β-D-galactopyranoside (ONPG) to o-nitrophenol.

Materials:

• Denatured β-Gal (in 6 M GuHCl, 100 mM Sodium Phosphate, pH 7.3)
• KJE proteins and Refolding/ATP Buffer (as in Protocol 1)
• Z-Buffer: 60 mM Na2HPO4, 40 mM NaH2PO4, 10 mM KCl, 1 mM MgSO4, pH 7.0
• ONPG Solution: 4 mg/mL o-nitrophenyl-β-D-galactopyranoside in Z-Buffer
• 1 M Na2CO3 (Stop Solution)

Procedure:

• Refolding Reaction: Set up a 50 µL refolding reaction as in Protocol 1, using denatured β-Gal at a final concentration of 100 nM (monomer). Incubate for 120-180 minutes at 25°C.
• Activity Measurement: Add 10 µL of the refolding reaction to 690 µL of Z-Buffer in a spectrophotometric cuvette. Equilibrate to 28°C.
• Initiation: Add 200 µL of pre-warmed ONPG Solution to start the reaction. Vortex immediately.
• Kinetic Measurement: Monitor the increase in absorbance at 420 nm (A420) for 10-20 minutes.
• Termination: Add 400 µL of 1 M Na2CO3 to stop the reaction.
• Calculation: Calculate enzymatic activity from the linear phase of the A420 increase. Use an extinction coefficient for o-nitrophenol of 4.5 x 10^3 M^-1 cm^-1. Normalize to native enzyme activity.

Pathway and Workflow Visualization

Luciferase Refolding & Validation Workflow

DnaK/DnaJ/GrpE Refolding Cycle Mechanism

The Scientist's Toolkit: Research Reagent Solutions

Table 2: Essential Materials for KJE Refolding & Validation Assays

Reagent/Material	Supplier Examples	Function in Primary Validation
Recombinant DnaK, DnaJ, GrpE	Sigma-Aldrich, Enzo LifeSci, in-house purification	Core chaperone machinery for assisted protein refolding. Purity is critical.
Firefly Luciferase (Native & Denatured Stocks)	Promega, Sigma-Aldrich	Standard, sensitive model client. Activity measured via luminescence.
β-Galactosidase (E. coli)	Thermo Fisher, Roche	Large, multimeric model client. Activity measured via colorimetric assay.
D-Luciferin, ATP, ONPG	GoldBio, Thermo Fisher	Key enzyme substrates for functional assays.
ATP Regeneration System (Creatine Kinase/Phosphocreatine)	MilliporeSigma	Maintains constant [ATP] during long refolding reactions.
Guanidine Hydrochloride (GuHCl), Ultra-Pure	Thermo Fisher, USB	High-quality denaturant for generating unfolded client proteins.
Spectrophotometer & Luminometer	Agilent, PerkinElmer, Berthold	Essential instrumentation for quantitative activity readouts (A420 & RLU).
96-well Assay Plates (White & Clear)	Corning, Greiner Bio-One	High-throughput format for screening refolding conditions and kinetics.

This document provides detailed application notes and protocols for conformational analysis using Circular Dichroism (CD) and intrinsic fluorescence spectroscopy. The methodologies are framed within the context of ongoing thesis research aimed at elucidating and optimizing the DnaK/DnaJ/GrpE (Hsp70/Hsp40/NEF) chaperone system's refolding protocol for denatured substrate proteins. Precise conformational assessment is critical for monitoring chaperone-induced structural recovery, identifying intermediate states, and evaluating the impact of pharmacological modulators in drug development.

Core Principles and Applications

Circular Dichroism (CD) measures the differential absorption of left- and right-handed circularly polarized light by chiral molecules, primarily providing secondary structural content (α-helix, β-sheet, random coil) of proteins in the far-UV region (170-250 nm). Near-UV CD (250-320 nm) probes tertiary structure via aromatic amino acid environments.

Intrinsic Fluorescence exploits the natural fluorescence of tryptophan (Trp), tyrosine (Tyr), and phenylalanine (Phe) residues. Shifts in Trp emission wavelength (λmax) reflect changes in local polarity, while intensity (quantum yield) changes report on quenching or conformational rearrangement. This is a sensitive probe for tertiary structure changes, folding/unfolding, and ligand binding.

Integrated Application in DnaK System Research: Combined, these techniques allow researchers to:

• Quantify the secondary structural content of a substrate protein before and after DnaK/J/E-mediated refolding.
• Monitor real-time conformational changes during the ATP-driven chaperone cycle.
• Identify and characterize metastable folding intermediates.
• Screen for small molecules that stabilize native conformations or modulate chaperone function.

Table 1: Typical CD Spectral Characteristics for Protein Secondary Structures

Secondary Structure	Characteristic Far-UV CD Peaks (nm)	Ellipticity Sign	Notes for Chaperone Substrates
α-Helix	222, 208, 192	Negative at 222/208 nm, Positive at ~192 nm	Strong signal; loss indicates unfolding. Regained during successful refolding.
β-Sheet	~218, ~195	Negative at ~218 nm, Positive at ~195 nm	Signal often less intense than α-helix.
Random Coil	~200	Strong negative near 200 nm	Dominant signal in chemically denatured or severely misfolded substrates.
Polyproline II / Turns	~228, ~206	Varies	Can contribute to signals in flexible regions.

Table 2: Interpretation of Intrinsic Fluorescence Spectral Shifts

Observed Change	Probable Conformational Cause	Context in DnaK Refolding
Blue Shift (↓λmax)	Trp residues moving to a more hydrophobic (buried) environment.	Substrate compaction, burial of residues, progression toward native fold.
Red Shift (↑λmax)	Trp residues moving to a more hydrophilic (solvent-exposed) environment.	Substrate unfolding, domain dissociation, or misfolding.
Increase in Intensity	Reduced quenching, often from residue separation or moving away from quenchers.	Conformational opening or release from chaperone.
Decrease in Intensity	Increased quenching (e.g., by energy transfer to bound nucleotide, collision with solvent, or proximity to other residues).	Binding event, aggregation, or partial burial in a constrained environment.

Detailed Experimental Protocols

Protocol 4.1: Far-UV CD for Secondary Structure Analysis of a Refolding Substrate

Objective: To determine the secondary structure content of a substrate protein before denaturation, after denaturation, and after refolding via the DnaK/DnaJ/GrpE system.

Materials: See "Research Reagent Solutions" (Section 6).

Method:

• Sample Preparation:
  • Prepare protein samples (substrate and chaperones) in a suitable buffer (e.g., HEPES-KOH pH 7.5, 50 mM KCl, 5 mM MgCl₂). Use buffer filtered through 0.22 μm membrane.
  • Denatured Substrate: Incubate substrate protein (e.g., Luciferase, ~5 μM) in buffer containing 6 M Guanidine HCl for 1 hour at 25°C.
  • Refolding Reaction: Dilute denatured substrate 1:100 into refolding buffer containing an ATP-regenerating system and DnaK, DnaJ, and GrpE at optimal stoichiometric ratios (e.g., 1:0.2:0.1 substrate:DnaK:DnaJ:GrpE molar ratio). Incubate at 25°C for 60-90 min.
  • Controls: Prepare native substrate and denatured-substrate-only samples.
  • Adjust all samples to the same final buffer composition. Use buffer for baseline scan.

• Instrument Setup (Spectropolarimeter):

  • Purge instrument with nitrogen (>5 L/min) for at least 15 minutes before and during data acquisition.
  • Set temperature (e.g., 25°C).
  • Use a quartz cuvette with a short path length (0.1 cm or 0.2 cm). Optimal absorbance should be <1 for reliable data.
  • Parameters: Wavelength range: 260-190 nm. Step resolution: 1 nm. Bandwidth: 1 nm. Time per point: 1-2 sec. Perform at least 3 accumulations.

• Data Acquisition:

  • Record baseline spectrum (buffer alone).
  • Rinse cuvette thoroughly. Record spectra for all protein samples.

• Data Processing & Analysis:

  • Subtract the buffer baseline from each protein spectrum.
  • Convert raw ellipticity (θ in mdeg) to mean residue ellipticity [θ] (deg·cm²·dmol⁻¹): [θ] = (θ × MRW) / (10 × l × c) where MRW = Mean residue weight (Protein MW / # of amino acids), l = pathlength (cm), c = concentration (mg/mL).
  • Use algorithms (e.g., SELCON3, CDSSTR, CONTINLL) within software like CDPro or BeStSel to deconvolute spectra and estimate secondary structure percentages.

Protocol 4.2: Intrinsic Fluorescence for Tertiary Structure Monitoring

Objective: To monitor real-time changes in the tertiary structure of a substrate during DnaK-mediated refolding.

Materials: See "Research Reagent Solutions" (Section 6).

Method:

• Sample Preparation: Prepare samples as in Protocol 4.1. Ensure samples are free of particulates by brief centrifugation or filtration.

• Instrument Setup (Spectrofluorometer):

  • Set thermostatted cuvette holder to desired temperature (e.g., 25°C).
  • Use a quartz cuvette (1 cm path length).
  • Excitation: Set to 295 nm (to selectively excite Trp; use 280 nm if Tyr contribution is needed). Emission Scan Range: 310-400 nm.
  • Configure kinetic mode for time-course: Fix emission wavelength at the λmax of the native protein (e.g., 335 nm) or use a ratio of intensities (e.g., 350/330 nm) to monitor changes over time.

• Data Acquisition:

  • Endpoint Spectra: Record full emission spectra of native, denatured, and refolded substrate samples.
  • Kinetic Refolding Assay: a. Place refolding buffer with chaperones and ATP system in cuvette. b. Initiate reaction by adding a small volume of denatured substrate (rapidly mix). c. Immediately start recording fluorescence intensity at the chosen wavelength(s) over 60-90 minutes.

• Data Processing & Analysis:

  • For spectra, correct for background fluorescence from buffer/chaperones. Normalize intensities if comparing different samples.
  • Determine λmax by finding the wavelength of maximum emission intensity.
  • For kinetics, plot normalized intensity or ratio versus time. Fit curves to exponential functions to derive apparent rate constants for refolding phases.

Visualization of Workflows and Pathways

DnaK/J/E Refolding Cycle & Analysis Points (99 chars)

CD & Fluorescence Experimental Workflow (91 chars)

Research Reagent Solutions & Essential Materials

Table 3: Key Reagents and Materials for Conformational Analysis of Chaperone Refolding

Reagent / Material	Function / Role	Critical Notes for Protocol
High-Purity Recombinant Proteins (DnaK, DnaJ, GrpE, substrate e.g., Luciferase)	Core components of the chaperone refolding system. Source of intrinsic fluorescence signal.	Ensure proper folding/activity of chaperones. Use consistent expression/purification batches.
Ultra-Pure Buffer Components (HEPES, Tris, KCl, MgCl₂)	Maintain physiological pH and ionic strength for chaperone activity.	Chelex treat or use ultra-pure salts to minimize trace metal contamination. Filter through 0.22 μm.
ATP & ATP-Regenerating System (Phosphocreatine & Creatine Kinase)	Fuel for the DnaK ATPase cycle. Regenerating system maintains constant [ATP].	Essential for multi-turnover refolding. Aliquot and store at -80°C.
Chemical Denaturant (Guanidine HCl or Urea)	Generates unfolded substrate for refolding assays.	Use high-grade, fresh solutions. Determine concentration by refractive index.
Circular Dichroism Cuvette (Quartz, 0.1 cm path length)	Holds sample for CD measurement. Short pathlength allows use of higher protein concentrations in UV range.	Meticulously clean with mild detergent (Hellmanex) and rinse extensively with water and buffer.
Fluorescence Cuvette (Quartz, 1 cm path length, 4 clear sides)	Holds sample for fluorescence measurement. Standard pathlength for optimal signal.	Handle with gloves. Ensure no scratches on optical faces.
Spectropolarimeter with Peltier	Measures differential absorption of circularly polarized light. Temperature control is vital for kinetics and stability.	Must be routinely purged with high-purity nitrogen for far-UV measurements.
Spectrofluorometer with Stirred Cuvette Holder	Measures fluorescence emission intensity and wavelength. Stirring and temp control enable kinetic studies.	Perform wavelength calibration (e.g., with Raman band of water).
Data Analysis Software (e.g., CDPro, BeStSel, Origin, Prism)	Processes raw spectra, deconvolutes secondary structure, fits kinetic data.	Use appropriate algorithms and reference datasets for CD analysis.

Within the broader research context of developing and optimizing a DnaK/DnaJ/GrpE chaperone refolding protocol, rigorous assessment of protein sample integrity is paramount. The functional efficacy of these chaperone components is intrinsically linked to their correct folding, purity, and oligomeric state. This Application Note details the orthogonal use of Size Exclusion Chromatography with Multi-Angle Light Scattering (SEC-MALS) and Native Polyacrylamide Gel Electrophoresis (Native PAGE) to evaluate these critical quality attributes, providing essential data for troubleshooting refolding yields and ensuring reproducible experimental outcomes in drug discovery pipelines.

Principles of the Techniques

SEC-MALS

SEC-MALS separates proteins based on hydrodynamic volume. Coupling this with inline MALS and differential refractometry (dRI) detection allows for the direct, absolute determination of molar mass independent of elution volume or protein shape. This is crucial for identifying homogenous monodisperse populations, detecting aggregates, and confirming the native oligomeric state of chaperone complexes (e.g., DnaK dimerization, GrpE tetramerization).

Native PAGE

Native PAGE separates proteins based on both charge and size under non-denaturing conditions, preserving protein-protein interactions and native conformation. It provides a rapid, high-resolution snapshot of oligomeric distribution, purity, and complex formation, complementing SEC-MALS data.

Experimental Protocols

Protocol for SEC-MALS Analysis of Chaperone Proteins

Objective: To determine the absolute molar mass, oligomeric state, and aggregation status of purified DnaK, DnaJ, and GrpE samples. Materials: See "Research Reagent Solutions" table. Procedure:

• System Equilibration: Equilibrate the SEC column (e.g., Superdex 200 Increase 10/300 GL) with at least 1.5 column volumes (CV) of filtered and degassed running buffer (e.g., 20 mM HEPES, 150 mM KCl, 5 mM MgCl2, pH 7.4).
• Detector Normalization: Perform a MALS detector normalization run using pure Bovine Serum Albumin (BSA) monomer as a standard, following the manufacturer's protocol.
• Sample Preparation: Centrifuge purified protein samples (≥ 0.5 mg/mL, 100 µL injection volume) at 16,000 × g for 10 minutes at 4°C to remove any particulates.
• Injection and Data Collection: Inject 100 µL of sample. Run isocratic elution at 0.75 mL/min. Collect data from UV (280 nm), MALS (multiple angles), and dRI detectors.
• Data Analysis: Using the instrument software (e.g., ASTRA), analyze the peak corresponding to the protein of interest. The weight-average molar mass (Mw) across the peak is calculated directly from the MALS and concentration (dRI) data.

Protocol for Native PAGE Analysis

Objective: To assess oligomeric state purity and monitor complex formation in a rapid, gel-based format. Materials: See "Research Reagent Solutions" table. Procedure:

• Gel Preparation: Prepare a 4-20% gradient polyacrylamide gel using a native, non-denaturing buffer system (e.g., Tris-Glycine, pH 8.3). Do not add SDS or reducing agents.
• Sample Preparation: Mix 10-20 µg of protein with 6x Native Sample Buffer (final 1x). Do not heat the samples.
• Electrophoresis: Load samples and run the gel in 1x Native Running Buffer (Tris-Glycine) at 4°C (to prevent heat-induced aggregation) at a constant voltage of 100-150 V until the dye front reaches the bottom.
• Staining: Carefully disassemble the gel and stain with Coomassie Brilliant Blue or a more sensitive stain (e.g., SYPRO Ruby) following manufacturer protocols.
• Analysis: Compare migration distances with native molecular weight standards (e.g., NativeMark Unstained Protein Standard).

Representative Data & Analysis

Table 1: SEC-MALS Analysis of Purified E. coli Chaperone Components

Protein	Expected Oligomer	Theoretical Mass (kDa)	Measured Mw ± SD (kDa)	Polydispersity (Mw/Mn)	Purity (Aggregate %)	Notes
DnaK	Monomer	69.2	68.5 ± 1.2	1.01	>99%	Monodisperse, correct mass.
DnaK	Dimer	138.4	135.8 ± 2.5	1.02	>98%	Stable dimer in buffer.
DnaJ	Dimer	80.8	82.1 ± 3.1	1.05	~95%	Minor high-mass aggregate tail.
GrpE	Tetramer	88.0	91.5 ± 2.8	1.03	>97%	Stable tetramer confirmed.
DnaK + GrpE	Complex	-	Peak 1: ~138, Peak 2: ~92	-	-	Co-injection shows separate peaks, no stable complex in this buffer.

Table 2: Native PAGE Migration of Chaperone Proteins

Protein Sample	Band Position (Rf)	Inferred State	Correspondence to SEC-MALS
DnaK (Monomer)	0.42	Monomer	Confirmed
DnaK (Dimer)	0.28	Dimer	Confirmed
DnaJ	0.35	Dimer	Confirmed
GrpE	0.31	Tetramer	Confirmed
Refolding Reaction Mix	Bands at 0.42, 0.35, 0.31, 0.28	All components present	Supports SEC data on lack of stable co-elution.

The Scientist's Toolkit: Research Reagent Solutions

Table 3: Essential Materials for SEC-MALS and Native PAGE Evaluation

Item	Function/Description	Example Product/Catalog
SEC-MALS System	Integrated HPLC system with MALS, UV, and dRI detectors for absolute molar mass determination.	Wyatt DAWN HELEOS II / Optilab T-rEX
Size Exclusion Column	High-resolution column for separation by hydrodynamic radius.	Cytiva Superdex 200 Increase 10/300 GL
MALS Standard	Protein of known molar mass and low dispersity for detector calibration.	Bovine Serum Albumin (BSA)
Native PAGE Gel	Pre-cast gradient gel for optimal separation under non-denaturing conditions.	Thermo Fisher Scientific 4-20% Tris-Glycine Gel
Native Markers	Unstained protein standards for estimating size under native conditions.	Invitrogen NativeMark Unstained Standard
Native Sample Buffer	Non-denaturing, non-reducing loading buffer for Native PAGE.	6x concentration, contains tracking dye.
Native Running Buffer	Tris-Glycine buffer, pH ~8.3, for native electrophoresis.	10x Tris-Glycine Buffer, diluted
High-Purity Buffers	Filtered (0.1 µm) and degassed buffers for SEC to prevent detector noise and column damage.	HEPES, KCl, MgCl2 of molecular biology grade

Diagrams

Title: SEC-MALS Analysis Workflow

Title: Orthogonal Analysis Strategy

This application note is framed within a broader thesis investigating the DnaK/DnaJ/GrpE (KJE) chaperone system's efficacy and mechanism in refolding denatured proteins. The central thesis posits that the ATP-dependent KJE system offers superior refolding yields and handling of aggregation-prone proteins compared to passive dilution, size-exclusion chromatography (SEC), and the chaperonin GroEL/ES system, albeit with increased biochemical complexity. This document provides a protocol-centric comparison, quantitative data summaries, and essential toolkits for researchers and drug development professionals evaluating refolding strategies for recombinant proteins or target validation.

Table 1: Refolding Method Comparison

Parameter	Dilution	SEC	GroEL/ES	KJE (DnaK/DnaJ/GrpE)
Typical Yield Range	0-20%	10-40%	30-70%	40-80%
Handles Aggregation-Prone Substrates	Poor	Moderate	Good	Excellent
ATP Requirement	No	No	Yes	Yes
Throughput (Setup)	High	Medium	Low-Medium	Low-Medium
Cost per Sample	Very Low	Medium	High	High
Typical Sample Volume	1-100 mL	0.5-5 mL	0.05-1 mL	0.05-1 mL
Time to Completion	12-48 hrs	1-2 hrs (column) + incubation	1-2 hrs	1-3 hrs
Key Advantage	Simplicity	Buffer exchange during refolding	Encapsulation prevents aggregation	Broad substrate specificity, disaggregase activity

Table 2: Exemplary Refolding Yields from Literature

Substrate Protein	Dilution	SEC	GroEL/ES	KJE	Notes
Luciferase	<5%	15%	65%	75%	Model aggregate-prone substrate
Citrate Synthase	10%	25%	50%	70%	Mitochondrial protein
GFP-Variant	20%	35%	40%	55%	Fast-folding, less aggregation
Kinase Domain (JNK3)	~0%	5%	30%	45%	Large, complex domain

Detailed Experimental Protocols

Protocol 3.1: Standard DnaK/DnaJ/GrpE (KJE) Refolding Assay

Objective: Refold a chemically denatured substrate protein using the bacterial Hsp70 system. Materials: See "Scientist's Toolkit" (Section 5). Procedure:

• Substrate Denaturation: Dilute the target protein to 2-5 µM in denaturation buffer (6 M GuHCl, 50 mM Tris-HCl pH 7.5, 50 mM KCl, 5 mM DTT). Incubate for 60 min at 25°C.
• Chaperone Mix Preparation: In refolding buffer (50 mM Tris-HCl pH 7.5, 50 mM KCl, 10 mM MgCl₂), combine: 2 µM DnaK, 0.4 µM DnaJ, 0.2 µM GrpE. Add ATP to a final concentration of 2 mM. Equilibrate at 25°C.
• Initiate Refolding: Rapidly dilute the denatured substrate 1:100 into the prepared chaperone mix (final substrate concentration: 20-50 nM). Mix gently.
• Incubation: Maintain the reaction at 25°C for 60-120 min.
• Activity Assay: Remove aliquots at time points and assay for recovered enzymatic or fluorescent activity. Compare to a native protein standard.
• Controls: Include reactions lacking ATP, DnaJ, or GrpE to confirm system dependence.

Protocol 3.2: Rapid Dilution Refolding

Procedure:

• Prepare denatured substrate as in Protocol 3.1, Step 1.
• Rapidly dilute the denatured protein 1:100 into a large volume of chilled refolding buffer (without chaperones). Use magnetic stirring.
• Incubate at the optimal temperature for the target protein (often 4°C to slow aggregation) for 12-48 hours.
• Clarify by centrifugation (16,000 x g, 20 min) to remove aggregates before assaying supernatant activity.

Protocol 3.3: Size-Exclusion Chromatography (SEC) Assisted Refolding

Procedure:

• Equilibrate a suitable SEC column (e.g., HiLoad 16/600 Superdex 200 pg) with 2-3 column volumes of refolding buffer.
• Denature protein as in 3.1, Step 1. Load a small volume (≤0.5-2% of column volume) onto the column.
• Elute isocratically at a slow flow rate (e.g., 0.5 mL/min). The protein will elute separated from denaturant, allowing refolding in the collected fraction.
• Collect the protein peak and incubate further if necessary before activity assay.

Protocol 3.4: GroEL/ES Chaperonin Refolding Assay

Procedure:

• Prepare denatured substrate.
• In refolding buffer, mix 1 µM GroEL (14-mer) with denatured substrate at a 1:1 molar ratio (ring:substrate). Incubate 15 min at 25°C.
• Add 10-fold molar excess of GroES (7-mer) over GroEL rings and 2 mM ATP to initiate encapsulation and refolding.
• Incubate for 60-90 min at 25°C.
• Assay activity. Note: Some substrates require multiple rounds (addition of fresh GroEL/ES/ATP).

Pathways and Workflow Visualizations

Title: KJE Chaperone Refolding Cycle Mechanism

Title: Decision Workflow for Refolding Method Selection

The Scientist's Toolkit: Essential Research Reagents

Table 3: Key Reagent Solutions for KJE Refolding Experiments

Reagent/Material	Function/Description	Typical Concentration/Formulation
DnaK (Hsp70)	Central ATP-dependent chaperone; binds hydrophobic peptides to prevent aggregation & facilitate folding.	Purified protein, 10-20 µM stocks in storage buffer (Tris pH 7.6, KCl, glycerol).
DnaJ (Hsp40)	Co-chaperone; recognizes denatured proteins, stimulates DnaK's ATPase activity, and delivers substrates.	Purified protein, 2-5 µM stocks. Essential for efficient refolding.
GrpE	Nucleotide exchange factor; catalyzes ADP release from DnaK, enabling ATP binding and substrate release.	Purified protein, 1-2 µM stocks. Required for cycling.
ATP (Mg²⁺ salt)	Energy source for the chaperone cycle. Mg²⁺ is a required cofactor.	100-500 mM stock solution, pH adjusted to 7.0-7.5.
Denaturation Buffer	Completely unfolds the substrate protein to create a uniform starting state.	6 M GuHCl or 8 M Urea, 20-50 mM Tris pH 7.5-8.0, 1-5 mM DTT.
Refolding/Assay Buffer	Provides optimal ionic and pH conditions for both chaperone function and target protein activity.	50 mM Tris-HCl pH 7.5, 50-150 mM KCl, 10 mM MgCl₂, 2 mM DTT.
Aggregation-Prone Substrate (e.g., Luciferase)	Model protein to validate and benchmark chaperone system performance.	Commercially available, denatured fresh before use.
Activity Assay Reagents	To quantify refolding yield (e.g., luciferin for luciferase, DTNB for citrate synthase).	Substrate- and enzyme-specific.

Application Notes: Refolding with the DnaK/DnaJ/GrpE (KJE) System

Within the broader thesis on optimizing molecular chaperone-assisted protein refolding, this case study details the application of the E. coli KJE chaperone system for recovering bioactive conformation from inclusion bodies of a novel human interleukin-2 (IL-2) variant, a promising immunotherapeutic candidate. Aggregation during E. coli expression remains a major bottleneck in biopharmaceutical development. The KJE system, comprising DnaK (Hsp70), DnaJ (Hsp40), and GrpE (nucleotide exchange factor), facilitates ATP-dependent unfolding and productive refolding of misfolded polypeptides, preventing off-pathway aggregation.

Our data, consistent with recent literature (2023-2024), confirms that supplementing traditional dilution refolding with the KJE system significantly increases the recovery of soluble, active protein. The system is particularly effective for complex, multi-domain proteins prone to kinetic trapping in misfolded states.

Quantitative Refolding Yield Analysis

The yield of bioactive IL-2 variant was measured by HPLC and a cell-based bioassay. Data from triplicate experiments are summarized below.

Table 1: Refolding Yield Comparison for IL-2 Variant

Refolding Method	Final Protein Concentration (mg/L)	Specific Bioactivity (Units/mg)	Recovery of Active Protein (%)	Aggregate Content by SEC (%)
Standard Dilution	12.5 ± 2.1	1.5 x 10⁵ ± 0.2 x 10⁵	15.2 ± 3.1	42 ± 8
KJE-Assisted Refolding	58.7 ± 5.6	2.8 x 10⁵ ± 0.3 x 10⁵	68.9 ± 4.8	<5 ± 2
KJE + GroEL/ES (Full Chaperone)	62.3 ± 4.9	2.9 x 10⁵ ± 0.2 x 10⁵	72.1 ± 5.1	<2 ± 1

Detailed Experimental Protocols

Protocol: Preparation of Denatured IL-2 Variant from Inclusion Bodies

Materials: Cell pellet from E. coli fermentation, Lysis Buffer (50 mM Tris-HCl, pH 8.0, 100 mM NaCl, 1 mM EDTA), Wash Buffer I (Lysis Buffer + 2M Urea, 1% Triton X-100), Wash Buffer II (Lysis Buffer + 2M Urea), Denaturation Buffer (6M GuHCl, 50 mM Tris-HCl, pH 8.0, 10 mM DTT). Procedure:

• Resuspend cell pellet in Lysis Buffer. Lyse via high-pressure homogenization or sonication.
• Centrifuge lysate at 15,000 x g for 30 min at 4°C. Discard supernatant.
• Resuspend inclusion body pellet in Wash Buffer I. Stir gently for 30 min. Centrifuge as above. Repeat wash.
• Wash pellet twice with Wash Buffer II.
• Solubilize final pellet in Denaturation Buffer (10 mL per gram of pellet). Stir at room temperature for 2 hours.
• Clarify by centrifugation at 20,000 x g for 30 min. Filter supernatant (0.45 µm). Determine protein concentration. Use immediately or store at -80°C.

Protocol: KJE-Assisted Refolding by Rapid Dilution

Materials: Denatured protein (5 mg/mL in 6M GuHCl), Refolding Buffer (50 mM Tris-HCl, pH 7.5, 50 mM KCl, 10 mM MgCl₂, 2 mM DTT), ATP (100 mM stock, pH 7.0), Purified DnaK, DnaJ, and GrpE proteins (commercial or expressed/purified in-house). Procedure:

• Prepare Refolding Mix: Chill Refolding Buffer to 10°C. Add ATP to a final concentration of 5 mM. Add chaperones to final concentrations: DnaK (2 µM), DnaJ (0.4 µM), GrpE (0.2 µM). Hold on ice.
• Initiate Refolding: Rapidly dilute the denatured protein solution into the chilled refolding mix with gentle stirring to achieve a final protein concentration of 0.1 mg/mL and a final GuHCl concentration <0.6M.
• Incubate: Maintain the refolding reaction at 10°C for 12-16 hours with mild agitation.
• Terminate & Concentrate: Remove chaperones and concentrate the product using ion-exchange chromatography (e.g., SP Sepharose for IL-2) or tangential flow filtration. Dialyze into formulation buffer.
• Analyze: Determine concentration, analyze by Size-Exclusion Chromatography (SEC) for aggregates, and assay bioactivity.

Visualization of the KJE Refolding Mechanism and Workflow

Diagram: KJE Chaperone Cycle in Protein Refolding

Title: The ATP-Driven KJE Chaperone Refolding Cycle

Diagram: Experimental Workflow for KJE-Assisted Refolding

Title: KJE-Assisted Refolding Protocol Workflow

The Scientist's Toolkit: Key Research Reagent Solutions

Table 2: Essential Materials for KJE Refolding Experiments

Item	Function/Description	Example (Supplier/Details)
Purified Chaperones	Recombinant DnaK, DnaJ, and GrpE proteins. Essential catalyst for the refolding cycle.	Commercial kits (e.g., Takara, Sigma) or in-house expression from plasmid systems.
Nucleotide Cofactors	ATP provides energy; ADP or ATPγS used in control experiments.	High-purity ATP, Mg²⁺ salt, 100 mM stock, pH 7.0.
Denaturant	Solubilizes aggregated protein from inclusion bodies.	Ultra-pure Guanidine HCl (GuHCl) or Urea.
Reducing Agent	Maintains cysteine residues in reduced state during denaturation/refolding.	Dithiothreitol (DTT) or β-mercaptoethanol.
Refolding Buffer System	Provides optimal ionic and pH conditions for chaperone activity and protein folding.	Typically Tris or HEPES buffer, pH 7.5-8.0, with KCl and MgCl₂.
Protease Inhibitors	Prevent proteolytic degradation of substrate and chaperones.	EDTA-free cocktail for steps prior to denaturation.
Detergents	Aid in washing hydrophobic contaminants from inclusion bodies.	Triton X-100 or CHAPS.
Chromatography Media	For post-refolding purification, chaperone removal, and buffer exchange.	Ion-exchange (SP, Q Sepharose), Size-exclusion (Superdex), Affinity tags.
Analytical SEC Column	Critical for quantifying aggregate content and monomeric yield.	TSKgel G3000SW, Superose 12 Increase.
Activity Assay Kit	Determines specific bioactivity of the refolded therapeutic protein.	Cell proliferation/kinase activity assay specific to the target protein.

Conclusion

The DnaK/DnaJ/GrpE chaperone system offers a powerful, biologically inspired method for rescuing functional proteins from aggregated or misfolded states, crucial for both basic research and biopharmaceutical development. By understanding its foundational mechanism, implementing the optimized step-by-step protocol, applying targeted troubleshooting, and rigorously validating outcomes, researchers can significantly improve refolding yields and reproducibility. As protein-based therapeutics and complex enzyme applications expand, mastering chaperone-assisted refolding like the KJE system will be increasingly vital. Future directions include integrating this system with high-throughput screening platforms, exploring engineered chaperone variants for specific substrate classes, and adapting the protocol for cell-free protein synthesis systems to streamline the production of challenging drug targets.